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ABSTRACT 
In this dissertation, two treatments, intraischemic hypothermia and 
glutamate receptor blockade, were evaluated for neuroprotective efficacy against 
global ischemia. Since the standard assessment of ischemic damage using only 
histological outcome reveals nothing about function, I used multiple outcome 
measures including behaviour and electrophysiology, as well as a histological 
evaluation. In order to further increase the strength of this approach, multiple 
assessments were made in the same animals. 
Intraischemic hypothermia induced by selectively cooling the brain 
conveyed both long-lasting protection against functional loss as well as cell 
loss. These fmdings provide a strong argument for the implementation of 
hypothermia in cases where the occurrence of an ischemic episode can be 
predicted before it occurs (e.g. elective cardiac/neuro-surgery). However, most 
cases of ischemia, or stroke, occur without warning thereby precluding the use of 
intraischemic hypothermia. 
NBQX, a glutamate receptor antagonist which selectively blocks the 
AMP A receptor, is reportedly neuroprotective when treatment is delayed several 
hours postischemia. The same approach developed to evaluate intraischemic 
hypothermia was ·used to study NBQX. In the course of these studies it was 
found that NBQX induced a mild, prolonged, hypothermic action. Due to the 
ability of hypothermia to mitigate ischemic damage and the confounding effects 
of hypothermia in previous pharmacological studies of ischemia, it became 
n 
important to determine whether the hypothermia induced by NBQX contributed 
to its mechanism of action. The results strongly suggest that NBQX conveys 
neuroprotection through a hypothermic action. These data raise important 
questions concerning current hypotheses of ischemic cell death, which currently 
focus primarily on involvement of the AMP A subtype of glutamate receptor. 
Finally, the behavioural changes that follow an ischemic episode were 
characterized with reference to variation in ischemic severity. Two types of 
behavioural alterations were noted: ( 1) an acute increase in activity following 
ischemia, and (2) a chronic increase in locomotor activity triggered by novel 
environments after the acute phase recovers. This second phase of increased 
locomotor activity was previously thought to reflect an impairment in spatial 
memory. Instead, it may be due to a form of behavioural sensitization not unlike 
that induced by stimulant drugs such as amphetamine. 
m 
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CHAPTER 1: INTRODUCTION 
1.1 Stroke 
Cerebral ischemia or stroke is a pathophysiological condition in which 
brain tissue is deprived of oxygen and glucose due to a reduction in blood flow. 
Global cerebral ischemia is commonly observed as a result of cardiac arrest, 
whereas occlusion of a cerebral artery supplying a specific region of the brain 
produces an area of focal ischemia. While progress has been made in recent 
I 
years in stroke prevention, primarily by making simple changes in lifestyle (i.e. 
dietary changes, exercise and quitting smoking), there remains no effective 
treatment for acute stroke when it does occur. In Canada there are approximately 
50,000 new cases of stroke each year, and this disease is currently the leading 
cause of disability, placing an enormous fmancial and emotional burden on 
society. In 1994, the financial cost of stroke due to medical care, rehabilitation 
and support services, plus the lost revenue from individuals whose disabilities 
prevented them from returning to work was estimated to be $1.6 billion per year 
(Sutherland and Peeling, 1994). Obviously, any therapy that would effectively 
reduce neuronal damage after ischemia would be of tremendous benefit. 
1.2 Animal Models of Ischemia 
The best way to develop treatments to combat cerebral ischemia is to 
model the events occurring during human stroke and cardiac arrest in animals 
1 
and then test the value of putative protective agents in these well-controlled 
models. Animal models developed for cerebral ischemia fall into two main 
categories: (i) focal and (ii) global models (see Ginsberg and Busto, 1989). Focal 
ischemia can be induced in a number of ways, one common method is to excise 
the cranium and transiently occlude (i.e. 1- 2 hours) the underlying middle 
cerebral artery with a removable clip (Buchan et al., 1992), or permanently occlude 
the artery by cauterization or ligation (Chen et al., 1986). An alternate method 
involves introducing a suture into the lumen of a major artery and advancing it 
up into the brain where it will occlude blood flow at the origin of the middle 
cerebral artery (Longa et al., 1989; Kawamura et al., 1991). As with the direct 
application of a vascular clip, focal ischemia induced with the suture model can 
either be transient or permanent because the suture can be retracted. Animal 
models of focal ischemia mimic what we typically think of as a stroke in humans 
and as 'with human clinical cases, the most common artery occluded in animal 
models is the middle cerebral artery. The resulting injury is an infarct, death of all 
tissue elements, in the region where blood flow has been severely reduced ( < 10 
ml/100g/minute). In the surrounding region, the penumbra, where the reduction 
in blood flow is not as great due to compensation from the collateral circulation, 
selective neuronal death may result (Astrup et al., 1981; Siesjo, 1992a,b). 
Models of global ischemia mimic the clinical condition of cardiac arrest in 
that a large region of brain tissue is ischemic. There are several ways of inducing 
global ischemia in animal models, these include cardiac arrest, inflation of a neck 
cuff and direct occlusion of the major arteries supplying the brain. In most 
mammals, occlusion of the pair of vessels supplying the forebrain, the carotid 
2 
arteries, will not result in forebrain ischemia because the posterior vertebral 
arteries can compensate for the lack of blood flow. The carotid and vertebral 
circulation is linked by communicating arteries which together form the circle of 
Willis at the base of the brain. Therefore, in order to induce forebrain ischemia, 
either the vertebral arteries have to be cauterized prior to bilateral occlusion of 
the carotid arteries, or severe systemic hypotension ( 45 - 50 mm Hg) has to be 
induced by exsanguination to prevent the collateral circulation from 
circumventing the effects of carotid occlusion. Both of these methods are 
commonly used in rat models of global ischemia and are referred to as the rat 4-
vessel occlusion model (4VO, Pulsinelli and Brierley, 1979) and 2-vessel 
occlusion model (2VO, Smith et al., 1984b ), respectively. The gerbil (Meriones 
unguiculatus) is different from most mammals in that it lacks a functional circle of 
Willis. Therefore, forebrain ischemia can be induced in the gerbil by occlusion of 
the carotid arteries only (Levine and Payan, 1966). The carotid arteries are 
isolated through a midline incision in the neck and then transiently occluded with 
vascular clips. Reproducible brain damage will result in regions such as the CAl 
sub field of the hippocampus, after occlusions as brief as 3 minutes (Mitani et al., 
1991; Andou et al., 1992), with a very low mortality rate. The advantage of the 
gerbil model over rat models of global ischemia is that the occlusion is not 
dependent on the success of the vertebral cauterization or strict maintenance of a 
blood pressure below 50 mm Hg. The disadvantage of this model is that 
physiological measurements, such as blood gases and blood glucose, cannot be 
easily obtained due to the smaller size of the gerbil in comparison to rats, and a 
correspondingly smaller blood volume. However, changes in many of these 
3 
physiological variables results in minimal variation in outcome in the gerbil 
model, with one exception being temperature which can have a large effect on the 
degree of ischemic damage (Clifton et al., 1989). 
In this thesis, I use a gerbil model of global ischemia in which I have 
developed a multi-faceted approach for measuring neuroprotection. This 
approach is used to evaluate the benefit provided by mild hypothermia, "Chapter 
3", and that of a selective glutamate a-amino-3-hydroxy-5-methyl-4-isoxazole 
propionate (AMPA) receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo(F)quinoxaline (NBQX), "Chapter 4". Finally, I have explored the heuristic 
value of careful behavioural analysis following ischemia and its use in predicting 
the severity of ischemic injury, "Chapter 5". 
The following sections describe the ionic and metabolic changes that 
occur during and after an ischemic event (1.3) and the pathology associated with 
global ischemia (1.4). 
1.3 Ionic, Metabolic and Other Pathological Perturbations During and 
Following Ischemia 
Due to the ·high metabolic rate and limited energy reserves, the brain 
requires a continual supply of glucose and oxygen. In addition, metabolic waste 
is normally removed by the circulatory system, preventing a build-up in the local 
area surrounding neurons and glia. Therefore, an interruption in the blood 
supply has serious consequences on brain metabolism and hence, brain 
function. Within ~ 30 seconds following circulatory arrest, the 
4 
electroencephalogram (EEG) flattens because ATP levels are not sufficient to 
maintain synaptic transmission. This is followed about 2 minutes later by an 
enormous shift in ionic balances (mainly Na + and K+) which require energy-
dependent processes for homeostasis (Hansen, 1985) and a massive extracellular 
accumulation of neurotransmitters including glutamate, aspartate, dopamine and 
y-aminobutyric acid (GABA) (Benveniste et al., 1984; Globus et al., 1988a). 
Within a few minutes of the ischemia, neurons become unresponsive to 
stimulation and, shortly after this, they depolarize causing a large negative shift 
in the extracellular potential, otherwise known as anoxic spreading depression 
(Somjen et al., 1990, 1993). Most neurons will recover from these events, 
depending on the duration of the ischemia, except the selectively vulnerable cell 
types (see section 1.4). 
In addition to the loss of ionic homeostasis, there is also an accumulation 
of metabolic waste. Due to the necessity to undergo anaerobic metabolism, lactic 
acid is one of the products that increases in large amounts (Siesjo et al., 1990) 
resultmg in a pH drop (reports range from 6.2- 6.9) (Silver and Erecinska, 1992; 
Kaku et al., 1993). The extent of acidosis is dependent on the glucose level prior 
to ischemia; hyperglycemia results in an increase in anaerobic respiration and 
hence a greater fall in pH. Acidosis has been hypothesized to be a major 
contributing factor to ischemic injury (Ljunggren et al., 1974), but more recent 
reports have suggested that the pH decline, provided it is relatively mild, may 
actually be beneficial (Kaku et al., 1993). High-energy phosphates are rapidly 
depleted during ischemia, but once reflow occurs A TP levels recover relatively 
quickly (within ~ 5 minutes) with the restoration of oxygen and glucose 
5 
(Sutherland et al., 1992). Other processes take longer to recover after ischemia. 
For example, glycogen stores and protein synthesis can take several hours to 
normalize (Nowak et al., 1985) and in some brain regions, such as CAl, protein 
synthesis may be irreversibly inhibited. Although, restoration of blood flow 
(oxygen, glucose and other constituents delivered by the circulatory system) is 
necessary to prevent neuronal death, reoxygenation may also contribute to the 
damaging process. With the restoration of oxygen, free radicals are formed 
which can lead to the destruction of neuronal membranes through lipid 
peroxidation reactions (Schmidley, 1990). 
I 
1.4 Pathology Following Global Ischemia 
Cell injury resulting from focal and global ischemia have different 
characteristics. Focal ischemia produces an area of dense ischemia, the ischemic 
core, where an infarct will develop in which all cellular elements are destroyed 
(i.e. neurons, glia and vascular tissue). Global ischemia, which is the type 
investigated in this thesis, is characterized by selective neuronal vulnerability. 
Certain classes of neurons display an enhanced susceptibility to global ischemic 
damage such that occlusion times that do not result in irreversible cell injury in 
most brain regions will kill these vulnerable neurons (e.g. CAl pyramidal cells). 
I 
Even within a brain region such as the hippocampal formation, there is a wide 
variation in the susceptibility of neurons to cell death following global ischemia. 
Some classes of intemeurons in the dentate hilus and stratum lucidum of CA3 are 
exceedingly vulnerable (Bratz and Grossmann, 1923; Johansen et al., 1985; 
6 
Johansen, 1993; Hsu and Buzsa.ki, 1993), where ischemic durations as brief as 2 
minutes will lead to cell death. Similarly, there is a profound loss of dorsal CA 1 
neurons (> 80 %) following ischemic episodes in excess of 3 minutes (Kirino 
1982; Mitani et aL, 1991; Andou et al., 1992) in the gerbil and 10 minutes in the rat 
(Pulsinelli et al., 1982). In contrast, nearby CA3 pyramidal cells and dentate 
granule cells can tolerate periods as long as 15- 30 minutes (Pulsinelli et al., 
1982). These wide differences in vulnerability within the hippocampal formation 
are not likely due. to differences in blood supply, but probably result from 
differences in the inherent characteristics of these individual neuronal 
populations and/or the pattern of innervation they receive (Schmidt-Kastner and 
Freund, 1991). However, the mechanistic reason for this vulnerability has 
remained a mystery since Sommer described the selective cell death in CAl, 
otherwise known as Sommer's sector, over 100 years ago (Sommer, 1880). In 
addition to the hippocampal formation selective neuronal vulnerability is found 
in (i) the striatum, where the small- and medium-sized spiny neurons are 
selectively injured by ischemia, (ii) Purkinje cells of the cerebellum and (iii) 
pyramidal neurons in layers 3, 5 and 6 of the neocortex (Pulsinelli et al., 1982; 
Crain et al., 1988). 
In addition to local differences in vulnerability, the type of cell death also 
varies. Some neurons (e.g. hilar intemeurons and striatal neurons) undergo rapid 
necrosis soon after the ischemic event, such that within 6 - 24 hours there is 
histological evidence of irreversible injury (Pulsinelli et al., 1982; Hsu and 
Buzsa.ki, 1993). Based on results from cell culture studies, the rapid rate of cell 
death was originally thought to be due to osmotic injury (Rothman, 1985), 
7 
whereas slow cell death appears to be dependent on Ca2+ (Choi, 1985). Cellular 
accumulation of N a+ during ischemia leads to an influx of cr down its 
electrochemical gradient. The increased osmolarity of the cell then results in a 
subsequent accumulation of water. If the osmotically driven influx of water 
exceeds the capacity of the plasma membrane for expansion, then cell death 
results. However, it is not clear whether cell lysis occurs in vivo (Benveniste, 
1991).· Therefore osmotic injury may not account for the rapid cell death of 
striatal neurons. 
Other neurons exhibit a different form of cell death which takes days to 
mature and appears to be mediated by Ca2+ (see Siesjo, 1988). This form of cell 
death has been termed delayed neuronal death and is a feature of postischemic 
necrosis in the CAl sector of the hippocampus where it was frrst described 
(Kirino, 1982). Pyramidal neurons in CAl appear normal histologically for 
approximately 48 hours postischemia and will also transiently recover synaptic 
responses after an ischemic event (Urban et al., 1989). However, the cells 
progress to necrosis 3 - 4 days after the occlusion. Recently, it has been found 
that the process of delayed neuronal death in the CA 1 region can be postponed 
by several weeks or months with certain anti-ischemic treatments, as discussed 
later in section 1.6 and Chapter 4. The mechanism underlying delayed neuronal 
death is unknown, however, there have been numerous hypotheses developed 
(e.g. glutamate excitotoxicity, see section 1.5). Most of the current hypotheses, 
including glutamate excitotoxicity, focus on increased intracellular Ca2+ as a 
common mechanism for the resulting cell injury. The hope offered by necrosis of 
the delayed type, from a clinical point of view, is that there may be a "therapeutic 
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windo~" after an ischemic insult when treatment could be administered which 
would halt or minimize the processes leading to delayed neuronal death. 
1.5 Glutamate Excitotoxicity 
Since the mid-1980's, there has been an explosion of knowledge pertaining 
to cell death induced by cerebral ischemia. For example, at the Society for 
Neuroscience annual meeting in 1984 there were no sessions specifically related 
to ischemia, since then the field has grown to such an extent that in 1994 there 
were 16 ischemia sessions and over 200 ischemia-related presentations. A 
contributing factor to this rapid growth over the last 10 years has been the 
interest in glutamate excitotoxicity (Choi, 1985; Rothman and Olney, 1986, 1987) 
and the hope that glutamate receptor antagonists, in particular N-methyl-D-
aspartate (NMDA) antagonists, would be beneficial as a clinical treatment for 
acute stroke (Gill et al., 1987). 
The glutamate excitotoxicity hypothesis is most often used to explain 
selective neuronal vulnerability to ischemia. The basic premise of the hypothesis 
is that glutamate rises above normal levels during ischemia and selectively 
vulnerable neurons are irreversibly injured by exposure to levels which are 
neurotoxic. The receptor which has been proposed to underlie glutamate 
excitotoxicity is the NMDA receptor. Since the NMDA receptor-gated channel is 
permeable to Na+, K+ and Ca2+, overstimulation of the NMDA receptor by 
glutamate could lead to a large accumulation of intracellular calcium (Ca2+i) 
thereby triggering a destructive cascade of events (i.e. activation of 
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Ca2+dependent proteases and lipases) leading to cell death (Choi, 1988; Siesjo 
and Bengtsson, 1989). The initial evidence that provided support for this 
hypothesis was that glutamate is neurotoxic in vitro and in vivo (Rothman and 
Olney, 1986) and brain regions that are vulnerable to ischemic injury tend to have 
the highest density ofNMDA receptors (Cotman et al., 1987). Moreover, 
cultured hippocampal cells do not die when exposed to hypoxic conditions if 
they have not developed synaptic connections, but once synaptic contacts form 
the neurons are susceptible to hypoxia (Rothman, 1983). This requirement of 
synaptic activity to trigger cell death has also been demonstrated in vivo by 
lesioning the input pathways to the CA 1 subfield prior to inducing ischemia 
(Benveniste et al., 1989; Kaplan et al., 1989). Lesioning afferents to the CAl 
region reduces the amount of glutamate released during ischemia (Benveniste et 
al., 1989), which might be a mechanism for the observed protection. Furthermore, 
intraischemic hypothermia which protects CA 1 neurons, decreases glutamate 
release during ischemia (Globus et al., 1988b; Mitani and Kataoka, 1991), whereas 
hyperthermia exacerbates both glutamate release as well as the subsequent 
neuronal injury (Mitani and Kataoka, 1991 ). 
However, the greatest support for the glutamate excitotoxicity hypothesis 
has come from a large number of studies using in vivo ischemia models (both 
global and focal) that have demonstrated protection against ischemic damage 
with NMDA antagonists (Gillet al., 1987; Park et al., 1988; Olney et al., 1989). 
Notwithstanding these results, some of the initial optimism regarding the use of 
NMDA antagonists to treat cerebral ischemia has been tempered by recent 
findings. First, glutamate concentrations measured in different brain regions 
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during ischemia do not predict the subsequent pattern of cellular injury. For 
example, glutamate concentrations in the CA 1 and CA3 regions are similar during 
ischemia, but the CAl region is considerably more vulnerable (Mitani et al., 
1992). Globus and colleagues have shown that the glutamate levels in the 
dorsolateral striatum and the anterior thalamus are virtually identical during 
ischemia, however, only the striatum displays selective vulnerability (Globus et 
al., 1991). Interventions that alter the glutamate concentration in the 
hippocampus during ischemia do not consistently alter the extent of cell injury, 
as do manipulations of intraischemic temperature. For example, theophylline 
increases glutamate release and kynurenic acid decreases glutamate release. 
However, neither intervention affects the magnitude of cell injury in the 
hippocampus following ischemia (Lekieffre et al., 1991, 1992). Second, although 
the CAl region has very high levels ofNMDA receptors and is quite vulnerable 
to ischemia, other brain regions have similar NMDA receptor levels and yet are 
resistant to damage (e.g. dentate granule cells). Third, and most importantly, the 
protection provided by MK-801, a potent non-competitive NMDA receptor 
antagonist, has been questioned. Several studies have suggested that MK-801 
is neuroprotective because of a hypothermic action, not through a direct 
pharmacological effect at NMDA receptors on CA 1 neurons (Buchan and 
Pulsinelli, 1990; Corbett et al., 1990; Nellgard et al., 1991; Hara et al., 1992). When 
MK-801 is administered and the hypothermic effects are prevented, there is little 
or no neuroprotection found. 
The above concerns regarding the excitotoxicity hypothesis, and in 
particular the questionable involvement of NMDA receptors in ischemic damage, 
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have caused ischemia research to focus on other subtypes of glutamate 
receptors. Recently, a selective AMP A receptor antagonist, NBQX has been 
found to be more protective against global ischemic injury than NMDA 
antagonists (Sheardown et al., 1990; Buchan et al., 1991a; Nellgard and Wieloch, 
1992; Sheardown et al., 1993) even with delayed treatment and there has been a 
suggestion for clinical trials to be initiated (Buchan et al., 1993). 
1.6 Assessment of Neuroprotection 
Assessment of ischemic cell damage in cases of severe injury is a simple 
matter of determining how many cells, if any, are remaining in a particular brain 
region (e.g. dorsal CAl). For example, in the gerbil model of bilateral carotid 
occlusion, with occlusion times of only 5 minutes, greater than 95 % of CA 1 cells 
are destroyed. In this case, assessment is relatively straightforward using 
standard histological methods. However, when protection against ischemic 
injury is evaluated following pharmacological treatment or other anti-ischemic 
therapies, the issue of de:fming neuroprotection becomes more complicated. For 
example, neuroprotection is usually assessed by counting the number of CA 1 
neurons remaining ~ 3- 7 days after the ischemic insult, a time when the majority 
of the cell population would have been destroyed in the absence of any 
intervention. It has been assumed that the presence of neurons at this stage 
indicates (i) that neurons whose histological appearance using a light 
microscope is normal must also be functionally intact and (ii) that the mere 
presen~e of cells a few hours to days beyond the time when they normally die 
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indicates permanent protection. Due to these assumptions, functional 
protection is not typically assessed, instead a histological measure of protection 
is usually the only endpoint used. However, cellular function can be 
compromised and behavioural performance can be impaired even when no 
neuronal injury is detected using conventional (i.e. Nissl stains) histological 
methods (Bothe et al., 1986; Jaspers et al., 1990; Miyazaki et al., 1992; Sekhon et 
al., 1994; Hori and Carpenter, 1994). In addition, when a treatment has been 
shown to provide neuronal protection during the first week, rarely are longer 
survival times assessed in order to verify that the protection persists. In the few 
cases where this has been done, decreasing efficacy of the treatment is often 
found at later survival times (Morse and Davis, 1990; Dietrich et al., 1993; 
Colbourne and Corbett, 1994a, 1995; Valtysson et al., 1994). Thus, at least in the 
CAl region, certain interventions (e.g. briefpostischemic hypothermia) simply 
prolong the time course of delayed neuronal death to weeks or months. 
These issues raise the important question of how is neuroprotection best 
defmed? Since functional protection cannot be assumed solely on the 
appearance of Nissl stained tissue, the assessment of neuroprotection should 
entail a measure of neuronal function. This is of paramount importance since the 
aim of ischemia research is to develop treatments for clinical use, in which the 
ultimate outcome measure is not histological, but functional preservation. 
N europrotection should also provide permanent savings. A treatment that does 
not preserve normal function and simply postpones cell death will be a 
disappointment if it eventually reaches clinical trials, not to mention the 
tremendous cost entailed. 
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In Chapter 3, I describe a method of functional assessment of ischemic 
animals that combines both behavioural and electrophysiological measures, with 
a subsequent histological quantification of hippocampal injury, all in the same 
animals. All measures have been designed to gauge the extent of injury in the 
CA 1 region since this is one of the most vulnerable regions to ischemia. 
Moreover, this is a brain region that undergoes delayed neuronal death and 
therefore, is amenable to postischemic treatment. 
1.7 Neuroprotective Therapies 
One of the most effective therapies in global ischemia to date has been 
hypothermia initiated during the period of ischemia. In contrast to earlier studies 
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in this field where hypothermia was moderate to severe (i.e. 18- 28 °C), it has 
been found that temperature need only be a few degrees below normal in order to 
provide protection against ischemic injury (Busto et al., 1987). In rodent models 
of ischemia, intraischemic hypothermia can occur spontaneously during surgery 
and in particular during ischemia itself. The blood supply is the major heat 
source to the brain and in small rodents once the blood supply is interupted the 
brain temperature will drop. Depending on the length of the occlusion, this 
spontaneous temperature decline is enough to protect neurons. This protective 
fall in brain temperature is unlikely to be as dramatic in humans during global 
ischemia due to the larger mass of brain tissue and a much thicker skull that 
provides insulation. 
These declines in brain temperature have been problematic in animal 
models of ischemia, causing a large variance in outcome, primarily due to 
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individual differences in intraischemic brain temperature. In view of the 
confounding influences of uncontrolled intraischemic temperature most 
investigators now control core and often brain temperature during surgery. 
However, the ease of cooling the brain during the ischemic period can be taken 
advantage of in order to study the protective effects of hypothermia. By 
deliberately cooling animals during the ischemic period, it is possible to have 
control over the magnitude and the rate of cooling. In Chapter 3, I have 
investigated the protective value of selective brain hypothermia during the 
ischemic event. Intraischemic hypothermia has been accepted as the gold 
standard for neuroprotection, but there has been little in the way of functional 
assessment following this protective strategy. Thus, intraischemic hypothermia 
was used in order to develop a functional assessment method for global ischemia 
that could be used in conjunction with a standard histological method of 
assessment . 
. In addition to intraischemic hypothermia, there have only been a few 
pharmacological therapies that have proven to be consistently protective when 
tested in different research labs. The glutamate AMP A receptor antagonist, 
NBQX, has received the most attention. Evidence from many studies using 
different models of global and focal ischemia has been in agreement with respect 
to the reproducibility of the neuroprotection afforded by this compound 
(Sheardown et al., 1990; Buchan et al., 1991a,b; Nellgard and Wieloch, 1992) and 
in contrast to previous studies with MK-801, where the protective action seems 
to result from a hypothermic effect, NBQX has not been reported to induce 
hypothermia (Sheardown et al., 1990). In addition to the protective effects of 
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NBQX, other evidence has supported the involvement of the AMP A receptor in 
ischemic injmy. Pelegrini-Giampietro et al. (1992) have found that ischemia 
causes a change in the mRNA coding for the subunits which make up the AMP A 
receptor. Following ischemia, there is a decrease in the message for the GluR2 
subunit which possesses the Ca2+ -impermeability property characteristic of the 
AMP A receptor (Hollmann et al., 1991 ). If the reduction in the mRNA for this 
subunit leads to the formation and expression of AMP A receptors without the 
GluR2 subunit, then activation of the AMP A receptor would lead to an increased 
calcium influx during normal glutamatergic stimulation. Activation of the AMP A 
receptor, even the configuration containing the GluR2 subunit, could be involved 
in ischemic injmy since activation of this receptor depolarizes neurons, thereby 
opening other channels that allow calcium entry (e.g. voltage-operated calcium 
channels and the NMDA receptor gated channel). By blocking the AMP A 
receptor, multiple sites for calcium entry are affected simultaneously, not just a 
single site as with NMDA antagonists. This effect along with changes in 
subunit composition, could explain the enhanced efficacy of NBQX compared to 
MK-801. However, the protection afforded by NBQX has only been subjected to 
histological verification and the survival times in global ischemia studies have 
only been ~ 4 - 7 days. Thus, after having developed a combined functional and 
histological approach to evaluate neuroprotection using intraischemic 
hypothermia, this assessment method was used to evaluate NBQX (Chapter 4). 
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1.8 Overview of Experiments 
1.8.1 intraischemic Hypothermia (Chapter 3) 
The aim of this study was to critically evaluate the protection afforded by 
intraischemic hypothermia against ischemic injury to the hippocampus. 
Hypothermic treatment was applied selectively to the brain during a 5 minute 
carotid artery occlusion. Following a period of recovery, independent functional 
measures were used to assess hippocampal function- (1) acute activity patterns 
during the frrst 3 - 5 hours postischemia, (2) an open field test which has been 
proposed to assess spatial memory (testing began 3 days postischemia) and (3) 
measurement of evoked potentials from area CAl in hippocampal slices (3 weeks 
after the ischemic episode). The functional outcome portrayed by these 
measures was compared to a morphological evaluation of CA 1 pyramidal cells at 
three rostro-caudallevels. All evaluations were carried out in the same animals. 
The outcome from these various assessments should indicate whether 
intraischemic hypothermia truly is the gold standard of neuroprotective 
treatments. 
This study introduces a novel approach for the evaluation of putative 
anti-ischemic treatments: combining behavioural, electrophysiological and 
histological measures. Each method of assessment may provide information 
relating to hippocampal integrity and when used in combination should yield a 
more accurate appraisal than any single outcome method. 
' 
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1.8.2 Evaluation of NBQX (Chapter 4) 
The same approach developed with intraischemic hypothermia was to be 
used to evaluate the protection afforded by postischemic treatment with NBQX, 
a glutamate AMP A receptor antagonist. NBQX had been repeatedly shown to 
protect against neuronal cell loss in several ischemia models without the 
confounding effects of hypothermia which had plagued other agents, such as 
MK-801. However, when pilot studies with NBQX began we detected that 
NBQX did produce hypothermia. Therefore, the proposed assessment of NBQX 
was modified to initially test the hypothesis that hypothermia contributed to the 
protective action ofNBQX. 
In initial studies two occlusion durations were used, 3 and 5 mimutes. At 
each occlusion duration a control group. received glucose vehicle, and four 
groups were treated with NBQX (3 x 30 mg/kg, intraperitoneal (i.p.)) starting at 
either 1 hour or 6·hours postischemia. At each time point the brain temperature 
in one of the NBQX groups was regulated so that it resembled the pattern in the 
vehicle controls and in the second NBQX group brain temperature was recorded 
but not regulated. This pilot study (11 treatment groups, n = 90) indicated that in 
our m~del, NBQX provided only minimal protection against 5 minutes of ischemia 
and was much more effective when given at 1 hour postischemia then if treatment 
was delayed for 6 hours. Therefore, the experiments in Chapter 4 focus on 
treatment with NBQX 1 hour after a 3 minute occlusion. This study was then 
followed with a further evaluation of the hypothermic effect ofNBQX as well as 
the functional protection provided by NBQX. 
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1.8.3 Locomotor Changes Associated with Ischemia (Chapter 5) 
In animal models of ischemia, both in the gerbil and rat, a frequently used 
behavioural hallmark of ischemic injury has been increased locomotor activity. 
However, reports .in the literature have varied with respect to the length of time 
this behavioural change persists after an ischemic episode, even in the same 
animal model with identical occlusion durations. I investigated whether these 
conflicting results were due to differences in the testing environments. 
Global ischemia was induced in gerbils for either 1.5, 3.0 or 5.0 minutes. 
Following ischemia the animal's activity was monitored in cages which the 
animals had been habituated prior to ischemia. Starting three days after surgery, 
locomotor activity was monitored for 10 minutes in an open field which was 
novel to the animals. Repeated open field testing was performed 7 and 10 days 
postischemia in some cases. All activity measures were compared to results from 
sham-operated animals. 
In the next chapter, Chapter 2, I describe the general methods employed 
throughout my thesis, some of the specific methodology is repeated when the 
experiments are described in Chapters 3 - 5. 
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CHAPTER 2: METHODS 
2.1 Animals 
All animal research was carried out in accordance with the animal care 
guidelines of Memorial University ofNewfoundland and the Canadian Council 
on Animal Care. For the majority of the experiments described, female Mongolian 
gerbils (Meriones unguiculatus) were used. Gerbils were purchased from High 
Oak Ranch Limited (Baden, ON, Canada (previously located in Goodwood, ON)). 
For the studies on the temperature effects ofNBQX, male, Sprague-Dawley rats, 
bred in the local animal care facility, were used in addition to gerbils. 
Gerbils were typically about 2 - 3 months of age upon arrival. They were 
housed in groups of four and acclimatized to the animal care facility for at least 
one week prior to experimentation. It was found that housing young animals 
individually for prolonged periods led to an increase in the number of animals 
who displayed seizures when handled (some strains of gerbils are known to be 
very seizure prone and these seizures can be triggered by novelty, Ludvig et al., 
1991 ). Although, with the breeder we use and the above method of housing we 
seldom observe seizures, perhaps 1 out of 50 animals will display a brief episode 
of ear and whisker twitching when being weighed at the initiation of an 
experiment. With the exception of 20 animals used in the intraischemic 
hypothermia experiments described in Chapter 2, all animals were treated with 
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piperazine citrate 0.34% w/v in the drinking water for 72 hours when they initially 
arrived. This antihelmenthic was given to treat pinworm infection which is a 
common affliction in gerbils and other rodents. Lights in the animal room were 
on a 12 hour light: dark cycle with lights on at 8 am. All animals were given food 
and w~ter ad libitum. The diet consisted primarily of guinea pig pellet food, 
supplemented with a rodent seed mixture which contained sunflower seeds and 
com kernels. Gerbils were often provided with shredded paper, papers towels or 
cardboard tubes which the animals shredded to make nests. 
2.2 Brain Temperature and Activity Monitoring 
With the exception of 3 normal animals used only for open field behaviour 
and CAl cell counts, brain temperature was monitored in all animals. Procedures 
for brain temperature monitoring have been described in Colbourne et al. (1993) 
and Nurse and Corbett (1994). A guide cannula was implanted 30-48 hours prior 
to braiD. temperature monitoring under barbiturate anaesthetic (sodium 
pentobarbital, 65-70 mg/kg i.p.), with atropine (0.02 mg/kg, subcutaneous) given 
prophylactically. The cannula was made from a 20 G needle and measured 5 mm 
in length. In some experiments a modified cannula was used, a bend was made at 
the top to form a 90° arm which acted as a platform for the temperature probe to 
rest on, tape was fitted under the arm and up and around the probe to secure it in 
place (modified cannula was designed by Fred Colbourne, unpublished 
methods). The cannula was positioned in a burr hole approximately 1 mm in front 
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of bregma and 2 mm to the left of the midline suture. The guide cannula was 
placed' so that it rested on dura, enabling the 8 mm brain probes to sample 
temperature from the dorsal striatum ( ~ 3 mm below dura), which was similar to 
the depth of the dorsal hippocampus. Thus, when the temperature probes were 
in place the readings obtained should have closely approximated the temperature 
in dorsal CA 1. In experiments involving electrophysiological recording, 
hippocampal slices were always prepared from the hemisphere opposite the 
cannula implant. Therefore, in these studies the cannula was placed either to the 
left or the right of the midline so that hippocampal slices could be sampled from 
the left or right, not solely from the right hemisphere. Once the guide cannula 
was positioned, two plastic screws (#MN-080-2, nylon machine screw, pan head 
#0-80 ~ 1/8", Small Parts Inc., Miami Lakes, FL, USA) were glued, head down, to 
the bone plates behind the coronal suture, using Lepage accu-flo™ super glue. 
Once the super glue had cured ( ~ 5 - 10 minutes) the guide cannula was 
cemented in place with dental cement. It was not possible to thread screws into 
the skull because of the thinness of the skull bone. A 27 G stylet was placed in 
the guide cannula, to keep the cannula patent. While the dental cement was 
hardening the skin was sutured and a fine tipped indelible marker was used to 
write the animal's identification number on the skull cap. All animals were 
housed individually after cannula implantation, with an identification card on the 
outside of the cage as well. Any time the animal was removed from its cage for 
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temperature monitoring, surgery, behavioural testing, etc. the ID on the skull cap 
was checked against the ID on the cage. 
Approximately 2 days after cannula implantation, an amplitude modulation 
(AM) type temperature probe (model XM-FH (8 mm), Mini-Mitter Co., Sun River, 
OR, USA) was inserted to sample normal brain temperature. Under halothane 
anaesthesia, {1.5 %in 30% 0 2/70% N20) the stylet was removed, the 
temperature probe was lowered into the cannula and secured with adhesive tape. 
Once the probe was in place, the animal was removed from the anaesthetic and 
put in a plastic cage resting on an AM-receiver (model# RA-1010, Catalog# 272-
0001, Data Sciences Inc., St. Paul, MN, USA) which measured temperature and 
activity by telemetry. 
The temperature readings were recorded on-line every 20 sec by reading 
the frequency output of the probe and converting it to a temperature using pre-
set calibration values. Calibration values at 33 oc and 38 oc were calculated for 
each probe approximately 48 hours after battery replacement and batteries were 
usually replaced when the period of temperature sampling reached 150 - 200 
hours. A thermocouple probe (HYP1-30-1/2-T-G-60-SMP-M) and a 
microprocessor thermometer (model HH23, both from Omega Technologies Co., 
Stamford, CT, USA) were used as the standard to which all brain probes were 
calibrated. For calibration, the brain probe and Omega thermocouple were floated 
in a 600 ml beaker containing 300 ml of water at the required temperature. The 
probes were extended into the water through small holes made in a plastic tissue 
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culture dish so that the tips of the two probes were at the same depth. Following 
calibration, the brain temperature probe had to read within 0.1 °C of the 
thermocouple probe to be considered accurate (accuracy was assessed between 
36-37 °C). 
Activity was scored as events by counting the number of times the 
automatic gain controller in the receiver had to adjust to maintain relative signal 
strength during each 20 sec sampling period. Each movement of the probe which 
caused a change in relative signal strength above the threshold value was scored 
as one event. Frequency measurements and activity measurements were 
independent of one another. All data were recorded with Dataquest III software 
(Data Sciences, Inc., St. Paul, MN, USA). 
Brain temperature and activity were typically recorded for a period of 3 
hours. Once the session was over the animal was briefly reanaesthetized with 
halothane as described above, the probe was removed from the guide cannula 
and replaced with the stylet. Animals were placed in their home cages and 
returned to the animal room. 
2.3 Cerebral Ischemia 
~Global forebrain ischemia was induced two days after normal brain 
temperature and activity had been monitored. Under halothane anaesthesia, the 
animal's head was wrapped in a flexible blanket ( Gaymar heat therapy Mul-T-
Pad™ model TP-3E, 3 1/2" x 23 ", Gaymar Industries Inc., Orchard Park, NY) which 
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could be used to heat or cool the brain by perfusing the blanket with warm or 
cold water, respectively. A small hole was made in the blanket, in an area that 
was sealed off from water flow, to allow the brain probe to pass through the 
blanket into the guide cannula. In some cases a needle thermistor (Model HYP 1-
30-1/2-T-G-60-SMP-M, Omega Technologies Co., Stamford, CT, USA) was 
inserted under the skin to measure temperature from the skull, on the side 
opposite the brain probe. After placing the brain probe (and skull probe), the 
animal was turned onto its back, a rectal probe was inserted to monitor core 
temperature and then the body was wrapped in an electrically heated blanket 
(Harvard homeothermic blanket control unit, small, Model# 50-7503, Harvard 
Apparatus Ltd., Edenbridge, Kent, UK). Core temperature was controlled with a 
homeothermic feedback system. Once the temperature probes and blankets were 
in place the only exposed area was the animal's neck. A midline incision was 
made and the carotid arteries were gently isolated and then looped with silk 
suture. A cotton ball moistened with saline was placed over the incision while 
waiting for the brain temperature to stabilize at normothermia (37.0 °C). Once the 
target temperature was reached, clamps were placed on both arteries and a 
stopwatch was started to time the duration of ischemia. Throughout the 
occlusion, brain temperature was kept as close as possible to 3 7 °C, except in the 
case where intraischemic brain hypothermia was deliberately induced. In these 
animals, following the initiation of ischemia, core temperature was maintained at 
normothermia as usual, but brain temperature was lowered to- 29- 30 oc (5 
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minute occlusions) or ~ 31 - 32 oc (3 minute occlusions) during ischemia by 
switching the water source for the head blanket from a heated water bath to ice 
cooled water, then rewarming immediately upon reperfusion. 
At the end of the ischemic episode, both arterial clamps were removed, 
reflow was visually confmned and the incision was sutured. Animals were 
removed from the anaesthetic setup, however, brain probes were left in place. 
The animals were placed in plastic cages, resting on the AM receivers, to record 
brain temperature and activity measurements. During the first hour of 
reperfusion, brain temperature was kept near normothermic values with a heating 
lamp if the animal was unable to maintain its own temperature. In some cases, 
rectal temperature was sampled periodically during the postischemic period. This 
was easily done by putting the animal on the counter top, grasping and lifting 
the base of the tail to expose the rectum and then inserting the thermometer 
parallel to the animal's spine (Digi-Sense Thermometer Model8523-00, Cole-
Parmer, Chicago, IL, USA). In the majority of animals sampled this way (both 
males and females) a lordosis response was induced and the animals remained 
motionless while the temperature was being taken, an unusual state for a gerbil! 
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Behaviour was periodically observed during the first hour post-surgery to 
determine the length of time it took for animals to right themselves and record 
whether "ischemic hunch" was apparent. This postural change, resulting from a 
kyphosis of the spine, was evident during the early period of reperfusion and is a 
neurological marker of ischemia. Any animal subjected to carotid occlusion for 3 
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or more minutes at normothermia who did not exhibit this postural change would 
not be expected to have functional or histological impairments. It is expected 
that some gerbils will have a circle of Willis (Mayevsky and Zipi, 1990) and 
therefore may not be affected by a transient clamping of the carotid arteries. 
However, even in gerbil populations where 10 to 20 % of the animals have some 
level of posterior communication, forebrain ischemia is still thought to be close to 
100 % during bilateral carotid occlusion because the additional vasculature is not 
sufficient to overcome the secondary vasoconstriction response that occurs 
during ischemia (Mayevsky and Zipi, 1990). The percentage of animals from the 
population of gerbils we use that show no evidence of ischemia related changes 
following occlusion of the carotid arteries is extremely low ( < 0.1 %) and none 
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were observed in the experiments described in this dissertation. 
Following temperature and activity monitoring, the brain probes were 
removed as described previously and the animals were returned to the animal 
room. Body weight was monitored during the postischemic recovery phase. 
Following ischemic episodes up to 5 minutes in length, an animal may display a 
transient weight loss but usually regains its pre-ischemic weight by 1 week post-
surgery. Animals continuing to lose weight at 1 week post-surgery would be 
considered unwell and behavioural measures could be confounded, thus not 
reflecting the true extent of ischemic injury. 
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2.4 Behavioural Testing 
Animals were tested in an open field to which they had not been exposed 
before ischemia/sham operations. The open field was a square wooden box, 72 x 
76 x 57 em, with a white Plexiglas insert that was used as the floor. Testing was 
carrie~ out in three 10 minute sessions 3, 7 and 10 days post-surgery (in 
experiments usin~ shorter survival times ( 4 days), there was only 1 open field 
test, 3 days post-surgery). A computerized tracking system divided the floor of 
the maze into 25 squares and counted the total number of squares entered by a 
gerbil during each trial as well as the total distance traveled (see Wang and 
Corbett, 1990). The gerbil was monitored by a camera (Panasonic CCTV camera) 
mounted above the maze and the image was displayed on a video monitor. Image 
analysis hardware was manufactured by HVS Image Analysing Ltd. (Hampton, 
England), tracking software was written by Chee Wong. All behavioural testing 
was carried out in a soundproofed room (2.1 x 3.4 m), distinctive features of the 
room &nd lighting conditions were kept constant from trial to trial. The room 
itself was dimly lit, however, the open field was lit from above by two 60 watt 
incandescent lights. The animals were kept in an outer room for a minimum of 20 
minutes before behavioural testing started, care was taken to disturb the animals 
as little as possible during this waiting period. These precautions were taken in 
the hope that the activity measurement in the open field would reflect "true" 
cognitive function and confounding factors such as behavioural arousal due to 
loud noises, transportation from the animal facility, being handled or weighed, 
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etc. would be minimized. Each cage was individually moved to the open field test 
room just before the trial for that animal, the animal was gently lifted out of its 
cage and placed in the comer of the maze, facing the centre. Once the animal was 
placed on the floor of the maze, the experimenter initiated computerized data 
acquisition and then left the room. The animal's behaviour could be viewed 
through a small window (31 x 31 em). At the end of the 10 minute session, the 
experimenter re-entered the test room, removed the animal from the open field and 
returned it to its home cage. The cage was then taken out of the test room, the 
floor o;f the maze was wiped with a sponge using mild, soapy water and dried. A 
similar procedure was then followed for each additional animal. Following open 
field testing, all animals were weighed and then returned to the animal care 
facility. 
2.5 Hippocampal Slice Preparation and Electrophysiological Recording 
Animals were anaesthetized with 2% halothane in 30%02 and 70% N 20. 
The head was enclosed in the cranial blanket used previously for ischemic 
temperature control and a brain probe was reinserted into the dorsal striatum. 
Brain temperature was gradually cooled without regulating core temperature, the 
percentage of halothane used to maintain anaesthesia was periodically reduced 
in 0.5% steps, from 2% down to 0.5%. Once brain temperature reached 30 oc (~ 
20 minutes), anaesthesia was discontinued for ~ 2 minutes while continuing to 
keep the head in contact with the cooling blanket. Animals were killed by 
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decapitation, the brain was quickly removed from the skull, placed on ice-cold 
filter paper and bisected. The hemisphere used for brain temperature monitoring 
was reserved for histology (immersion fixed in 10% buffered formalin) and 
hippocampal slices were prepared from the other. Briefly, the hippocampus was 
dissected free, transverse sections (500 f..lm) from the middle half of the 
hippocampus (along the septotemporal axis) were obtained with a tissue chopper 
(Model# 51425, Stoelting, Wood Dale, IL, USA) and transferred to a holding 
chamber containing modified artificial cerebrospinal fluid (ACSF) consisting of 
(mmol/L): sucrose 215.8; KC13.5; CaC12 2.0; NaHC03 25.0; NaHP04 1.2; MgCh 1.3; 
glucose 11.0, bubbled with 95%02/5% C02 (pH 7.3 - 7.4). Slices were incubated 
at room temperature in modified ACSF for 15 minutes and subsequently in normal 
ACSF which contained (mmol/L): NaC1126.0; KC13.5; CaC12 2.0; NaHC03 25.0; 
NaHP04 1.2; MgCb 1.3; glucose 11.0, saturated with 95% 0 2/5% C02 (pH 7.3 -
7.4) for at least 1 hr prior to experimentation. 
Extracellular recording of evoked potentials was carried out using a 
submerged slice preparation in a perfusion chamber at 33- 34 °C. The slice was 
superfused with warmed, oxygenated ACSF at a rate of 2 mVminute. Recording 
electrodes, glass micropipettes were filled with 2M N aCl. Twisted, bipolar 
tungsten stimulating electrodes (Teflon-coated, tip separation 125 f..lm) were used 
for orthodromic stimulation of perforant path and Schaffer-collateraVcommissural 
fibers with constant current pulses (0.1 ms and 20 f..lS, respectively; stimulus 
intensities ranged from 50- 800 f..lA) delivered at the rate of0.05 Hz (ST -101 
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Stimulator, Stimtek, Acton, MA, USA), triggered by a computer. Recordings 
were amplified and filtered (ftlter settings were from 0.1 Hz to 10KHz) (DAM-5 
differential preamplifier, World Precision Instruments, Sarasota, FL, USA), 
displayed on an oscilloscope and digitized for display, storage and subsequent 
analysis through a Lab Master DMA board (Scientific Solutions Inc., Solon OH, 
USA, 12-bit AID converter, AID conversion rate was 0.02 msec). Software for 
stimulation triggering (including theta frequency stimulation for induction of 
long-term potentiation and paired pulse stimulation), data collection, and 
analysis of excitatory post-synaptic potentials (EPSPs) and population spikes 
was written in Asyst (Version 4.00, Asyst Software Technologies, Inc., 
Rochester NY, USA). The software is available from the author. 
Slice viability was determined by visual inspection and orthodromic 
stimulation of the perforant path. If a slice appeared viable and perforant path 
stimulation could. elicit a population spike in the dentate granule cells then it was 
used for recording in CA 1, otherwise it was discarded and no recording in CA 1 
was attempted. Field potentials for area CA 1 were measured in stratum radiatum 
following stimulation of the Schaffer collaterals, an input/output series was used 
to determine the maximum EPSP amplitude. Input/output series were performed 
in a random order, with 3 - 4 stimulations at each intensity in the log series. Once 
the maximal response was determined all subsequent recordings were made with 
the stimulus intensity at the setting which produced the half-maximal response. 
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2.6 Histopathology 
All brain tissue to be used for histological assessment was fixed in 10 % 
buffered formalin. If electrophysiological recording was not carried out then the 
animal was given a lethal injection of sodium pentobarbital (0.1 ml, approximate 
dose= 100- 130 mg/kg), transcardially perfused with heparinized saline (heparin 
sodium, 2.5 units/ml) for 1.5 minutes(~ 15 ml) followed by 60 ml10% phosphate-
buffered formalin (SF100-20, Fisher Scientific, Montreal, PQ, Canada). The 
descending aorta was clamped off during perfusion so that only the upper body 
and head were fixed. A syringe pump (Model A, Razel Scientific Instruments, 
Stamford, CT, USA) was used to infuse the perfusate. Following fixation, the 
animal was decapitated and the brain was left in situ overnight, in the same 
fixative. The following day the brain was extracted from the skull and left in 
fixative for approximately 3 more days. It was found that taking the brain out of 
the skull immediately following the perfusion led to dark neuron artifact in some 
cells due to mechanical compression of the brain tissue during extraction. In 
order to avoid this artifact, which could be confused with ischemic cell change, 
the brains were left in situ for~ 24 hours (Cammermeyer, 1961), until the tissue 
hardened from the fixative. If electrophysiology was carried out, the animal was 
cooled and decapitated as stated previously, the brain bisected and then the 
hemisphere used for brain temperature sampling was immersion fixed in 10 % 
buffered formalin· phosphate for at least 4 days prior to embedding or freezing . 
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For histological assessments of CAl the brains were blocked (to remove 
the cerebellum and the region rostral to the nucleus accumbens) and frozen in 
' petroleum ether (cooled with C02 in acetone) prior to being sectioned in the 
coronal plane at 10 f.liD using a cryostat set at -18 °C. In later studies, the blocks 
were dehydrated, ·embedded in paraffm and 6 f..Lm sections were cut on a 
microtome. Tissue was cut starting at the level of the vertical limb of the 
diagonal band of Broca through to the level of the red nucleus. Sections were 
collected on glass slides (slides were gelatin coated for the collection of frozen 
sections), air dried overnight, then stained with either cresyl violet, cresyl violet 
plus phloxine, or haematoxylin and eosin. Neurons that have died or undergone 
irreversible injury, but are still present, prior to fixation are acidophilic and will 
preferentially take up acidic stains (i.e. phloxine and eosin). In contrast, cells that 
were alive at the time of fixation preferentially bind basic Nissl stains (i.e. cresyl 
violet and haematoxylin). This difference in staining when tissue has been 
double stained with a basic and an acidic dye helps distinguish between cells 
that appear 'histologically normal' and those that are not at the time of fixation. 
Acidophilic cells were excluded from the cell counts of the CA 1 region. Neurons 
which are acidophilic correspond to cells that are disintegrating when visualized 
with electron microscopy. In such cases, there is a breakdown of cellular 
structures (such as the plasma and nuclear membranes), loss of the endoplasmic 
reticulum and Golgi apparatus from the cytoplasm and the appearance of 
mitochondrial flocculent densities (Brown et al., 1979; Auer et al., 1985). 
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Depending upon the survival time after ischemia, many of the cells that were 
killed by the ischemic episode may have died and been phagocytosed, thus 
would not stain at all. Therefore, it is not possible to count the number of cells 
that have died by counting the acidophilic cells, since this may only represent a 
subpopulation of the cells that were actually killed by the ischemia. In order to 
determine the proportion of cells that were killed, the number of basophilic cells 
remaining must be assessed and then compared to counts/ratings from normal or 
sham-operated animals. 
Hippocampal injury was assessed, while blind to treatment status, in one 
of two ways. In earlier studies, sectors 400 J.lm in length of the dorsal and ventral 
CA 1 pyramidal cell band were rated at three levels posterior to bregma; 1. 7 mm (3 
dorsal sectors: medial, middle and lateral), 2.2 mm ( 4 sectors: medial, middle, 
lateral and ventral) and 2.8 mm (2 sectors: middle and ventral), see Figure 3-9. 
The percentage of neurons in each sector which appeared viable (i.e., had well-
defined nuclei and were basophilic), relative to a normal gerbil hippocampus, 
were rated using a five-point scale where: 0 = 0 - 5%, 1 = 6 - 29%, 2 = 30 - 59%, 3 = 
60 - 89% and 4 = 90 - 100%. We have examined the precision of this rating scale 
in relation to actual cell counts and found a high correlation r = 0.97, p = 0.0001 (n 
= 56, unpublished observations). Assessment of ischemic damage using the 
above rating scale is also associated with a high degree of inter-rater reliability. 
However, the literature in the field of cerebral ischemia is filled with a plethora of 
different rating scales, many of which use only a three-point scale: 1 = no injury 
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(i.e.< 20 %), 2 =some injmy (i.e. 20- 80 %) and 3 =extensive cell loss (i.e.> 80 
% ). Since numerous rating scales are essentially all or none and do not 
distinguish gradations of injury, i.e. 25 %versus 50% versus 75 %, many 
reviewers are insisting on cell counts and discouraging the use of any rating 
scales. Therefore, in later studies, assessment of CAl injury was based on cell 
counts in order to comply with the movement away from rating scales. 
Unfortunately, the inordinate amount of time involved in doing cell counts limits 
the amount of tissue that can be assessed. When tissue was assessed by doing 
cell counts, 3 sectors were counted in a rostral section of dorsal CA 1, 1. 7 mm 
posterior to bregma ( see Figure 3-9A). 
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CHAPTER 3: 
DIRECT MEASUREMENT OF BRAIN 
TEMPERATURE DURING AND AFTER 
INTRAISCHEMIC HYPOTHERMIA 
(CORRELATION WITH BEHAVIOURAL, 
ELECTROPHYSIOLOGICAL AND 
HISTOLOGICAL ENDPOINTS) 
3.1 Introduction 
Global cerebral ischemia can result in irreversible brain damage, most 
noticeably in the CA 1 sector of the hippocampus. In both humans and animal 
models this necrosis is delayed, and using standard histological procedures such 
as Nissl stains, is undetectable for 2- 4 days following the ischemic insult and 
may take at least 7 days to be complete (Kirino, 1982; Pulsinelli et al., 1982; Hom 
and Schlote, 1992). However, cell death is preceded by a decay in the evoked 
response of CA 1 pyramidal cells to Schaffer collateral stimulation (Urban et al., 
1989, 1990). In hippocampal slices taken from animals that have previously 
undergone an episode of cerebral ischemia, electrophysiological function can be 
preserved by intracellular injection of Ca2+ chelators and deterioration is 
hastened by IP3 activation (Kirino et al., 1992; Tsubokawa et al., 1992). This 
evidence suggests that the irreversible alteration in electrophysiological 
response following ischemia is Ca2+ -dependent. Abnormal Ca2+ homeostasis is 
also thought to be the trigger for the subsequent neuronal death (Choi, 1985; 
Siesjo 'and Bengtsson, 1989). Thus, deterioration in the evoked response of CAl 
neurons to afferent stimulation could be used as an early marker of cell death. 
Putative neuroprotective treatments, such as glutamate receptor 
antagonists (Warner et al., 1990) or prior lesioning of excitatory amino acid inputs 
(Kaplan et al., 1989), have been reported to preserve CAl cells histologically for 
several weeks. However, if these cells are examined using silver impregnation 
their appearance is similar to a transition state observed in untreated animals 24 -
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48 hours after ischemia, when electrophysiological function has been lost, 
though neurons are still considered viable (Warner et al., 1990). Thus, it may be 
that certain anti-ischemic treatments which have appeared neuroprotective 
simply slow down cell death by several days or weeks, but do not preserve 
function. Since most researchers tend to quantify ischemic damage using 
survival times of 3 - 7 days and rely solely on N issl stained material, a normal or 
near normal appearance does not necessarily reflect preserved function or long-
term protection. Consequently, the electrophysiological responsiveness of CAl 
pyramidal cells may be a more sensitive measure of CA 1 integrity than 
histolo,gical assessment alone, especially in cases where "protective treatments" 
have been administered. 
Cell death resulting from global ischemia can lead to memory deficits in 
rodents and primates (Zola-Morgan et al., 1986,1992; Auer et al., 1989; Corbett et 
al., 1992). Neurobehavioural tests of memory function have been shown to be 
sensitive indices of hippocampal cell loss resulting from ischemia. Even 
following mild cases of ischemia, which have not resulted in detectable CAl cell 
loss, deficits in spatial memory function were evident several days after 
occlusion (Jaspers et al., 1990). Following unilateral ischemia in non-sensitive 
gerbils (i.e. blood flow was only temporarily reduced to~ 30% of normal due to 
compensation by the collateral circulation) there were detectable memory 
impairments even though the occlusion produced no histological injury (Bothe et 
al., 1986). However, following a longer survival period, 8 weeks, neuronal cell 
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death became evident. Thus, the early behavioural test had been more sensitive 
to the ultimate outcome than early histological assessment. Therefore, it is 
crucial to combine behavioural testing with histological assessment in order to 
dete~ine whether putative neuroprotective treatments preserve cognitive 
functions as well as neurons, since this is the ultimate goal. However, with 
increasing recovery time memory impairments can be less evident unless more 
intricate tests are employed. For example, we were able to show a deficit in 
Morris water maze performance using the simple place learning task starting 3 
days, but not 3 weeks, following ischemia (Corbett et al., 1992). Other 
researchers (Auer et al., 1989; Green et al., 1992) revealed a protracted memory 
impairment by employing the more difficult place learning-set variation of this 
task 6 - 8 weeks after ischemia. Recovery of function has been demonstrated in 
other memory tests as well (Imamura et al., 1991; Katoh et al., 1992) and is 
presumably due to compensation by undamaged structures within the 
hippocampal formation itself or other brain regions. The ability of the nervous 
system to compensate for neuronal loss can complicate the interpretation of 
behavioural tests if they are used in isolation. 
Since behavioural, electrophysiological and morphological evaluations 
can all be used to assess outcome following cerebral ischemia, combining all 
three should provide a powerful method for gauging the efficacy of a 
neuroprotective treatment. If each of these measures are reliable indicators of 
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CAl integrity, and if a treatment strategy has been truly beneficial, then 
converging evidence for neuroprotection should be obtained. 
The objective of the present study was to evaluate the protection afforded 
by intraischemic hypothermia using the above multi-faceted approach. It is well 
known that mild to moderate intraischemic hypothermia can provide near total 
protection of CAl neurons from ischemia (Busto et al., 1987; Chopp et al., 1989; 
Minamisawa et al., 1990a, 1990b; Welsh et al., 1990; Dietrich et al., 1993; Iwai et 
al., 1993). Hypothermia has been suggested to be the "gold-standard" to which 
other therapies should be compared (Buchan, 1992), thus it seemed the best 
candidate against which to evaluate the potential sensitivity of the above 
functional and histological measures of ischemic injury. Ischemia was induced 
by occluding the carotid arteries for 5 minutes in gerbils, while brain temperature 
was either maintained at normothermia or lowered to ~ 30 °C. These groups were 
compared to sham -operated controls in a novel open field maze, a test which has 
previously been shown to reliably reflect the extent of CAl damage (Gerhardt 
and Boast, 1988; Wang and Corbett, 1990; Mileson and Schwartz, 1991; Babcock 
et al. , 1993). After a 3 week survival period, hippocampal slices were prepared 
from one hemisphere in order to measure the responsiveness of CA 1 neurons to 
afferent stimulation, while the other hemisphere was retained for histological 
analysis. Thus, the behavioural, electrophysiological and histological measures 
were all derived from the same animals. 
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3.2 Materials and Methods 
3.2.1 Animals 
Twenty adult female Mongolian gerbils (High Oak Ranch, Goodwood, ON) 
were used in this study. At the initiation of the experiment, animals were 3.5- 6 
months of age and ranged in weight from 55 - 90 g. 
3.2.2 Preparation for Brain Temperature Measurement 
Guide cannule (5 mm) for the brain temperature probes were implanted 
either above the left or right hemisphere, as described in the general methods 
section 2.2. Two days prior to ischemia/sham surgery, striatal temperature was 
measured continuously for three hours to provide baseline values. 
3.2.3 Cerebral Ischemia 
Anaesthesia was induced with 2% halothane and maintained with 1.5% 
halothane in 30%02 and 70% N20. Rectal, skull and brain temperatures were 
measured as previously described in the general methods section (section 2.3). 
Rectal temperature was maintained between 37.8 and 38.0 oc throughout the 
surgical procedure. Brain temperature was maintained near 37.0 °C with a 
separate blanket system heated by a water bath. This blanket was in direct 
contact with the top and sides of the head in order to distribute heat to the brain 
as evenly as possible. The common carotid arteries were isolated through a 
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midline incision in the neck and looped with silk suture. After carotid isolation 
animals were divided into three treatment groups: (1) 5 minute ischemia at 
normothermic brain temperature (NBT; n = 7), (2) 5 minute ischemia with 
intraischemic brain hypothermia (IBH; n = 7) and (3) a sham-operated control 
group, treated comparably to ( 1) except for the induction of ischemia (SHAM; n = 
6). Cerebral ischemia was induced by placing vascular clamps on the carotid 
arteries for five minutes. Following clamp removal reflow was confmned visually 
and the incision sutured. Brain temperature was lowered in the IBH group by 
promptly changing the water source for the head blanket from the heated water 
bath to an ice-bath just as the arteries were being occluded. Once the brain 
temperature reached~ 30.0 °C the water temperature was adjusted to maintain a 
steady state. Upon reperfusion, normothermia was restored by reverting to the 
original water source. 
Once brain temperatures returned to the preischemic level ( 5 minutes or 
less in the NBT group and ~ 10 minutes post-occlusion in the IBH group), the 
skull thermistor and rectal thermometer were removed and anaesthesia was 
discontinued. Duration of the entire surgical procedure was similar in all 3 
groups, approximately 30-35 minutes. Brain temperature monitoring continued 
after surgery for at least 3 hours in unrestrained animals, rectal temperature was 
sampled twice, 30 and 60 minutes postischemia. Postischemic brain temperature 
data for one animal in the sham-operated control group had to be excluded 
because of irregular readings due to battery failure. 
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3.2.4 Behavioural Testing 
Animals were tested in an open field maze (72 x 76 x 57 em) to which they 
had not been exposed before ischemia/sham operations. Testing was carried out 
in three 10 minute sessions 3, 7 and 10 days post-surgery. The floor of the maze 
was divided into 25 squares and a computerized tracking system counted the 
total niunber of squares entered during each trial (see section 2.4). All 
behavioural testing was carried out in a soundproofed room (2.1 x 3.4 m). 
Distinctive features of the room and lighting conditions were kept constant for 
the duration of the experiment. 
3.2.5 Hippocampal Slice Preparation and Electro physiological Recording 
Twenty-one to twenty-three days following ischemia/sham surgery 
animals were anaesthetized with 2% halothane in 30%02 and 70% N20. The 
head was again enclosed in the cranial blanket and a brain probe reinserted into 
the striatum. Brain temperature was gradually lowered as described in section 
2.5. Animals were killed by decapitation, the brain was quickly removed from the 
skull, placed on ice-cold filter paper and bisected. The hemisphere used for brain 
temperature monitoring was reserved for histology (see below) and hippocampal 
slices were prepared from the other. Hippocampal slices (500 pm) were incubated 
at room temperature in modified ACSF (containing sucrose in place ofNaCl) for 
15 minutes and then transferred to normal ACSF for~ 2 hours prior to recording. 
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Extracellular recording of evoked potentials was carried out using a 
submerged slice preparation in a perfusion chamber. Recording electrodes, glass 
micropipettes (tip diameter~ 20 J.liil, resistance 0.5- 1.0 MQ), were filled with 2M 
NaCl in 0.5% agar. Twisted, bipolar tungsten stimulating electrodes were used 
for orthodromic stimulation of perforant path and Schaffer-collateraVcommissural 
fibers with constant current pulses ( 1 00 and 20 J.ls, respectively) delivered at the 
rate of 0.05 Hz. Recordings were digitized for storage and subsequent analysis. 
The experimenter was blind to treatment status while carrying out the 
electrophysiological investigation. A slice was considered viable if orthodromic 
stimulation of the perforant path could elicit a population spike in the dentate 
granule cells, otherwise it was discarded and no recording in CA 1 was attempted. 
3.2.5 Histology 
The hemisphere retained for histological analysis of CAl and brain probe 
placement was fixed by immersion in 10% phosphate-buffered formalin. The 
brain tissue was frozen in petroleum ether (cooled with C02 in acetone), 
sectioned in the coronal plane at 10 J.lm and stained with cresyl violet. Sectors of 
the dorsal and ventral CA 1 pyramidal cell band ( 400 J.lm in length) were rated 
blindly. at three levels posterior to bregma; 1.7 mm, 2.2 mm and 2.8. The 
percentage of neurons in each sector which appeared viable (i.e., with well-
defmed nuclei), relative to a normal gerbil hippocampus, were rated using a five-
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point scale where: 0 = 0-5%, 1 = 6-29%,2 = 30-59%,3 = 60-89% and4 = 90-
1000/o. 
3.2.6 Statistics 
Brain temperature, open field scores and CA 1 evoked potentials were 
analyzed using ANOV A. Individual post-hoc comparisons were evaluated using 
Dunnett's t-test (two-tailed). Histological results were analyzed with the 
Kruskal-Wallis test. Significance level was initially set at p < 0.05. 
3.3 Results 
Intraischemic brain hypothermia was achieved rapidly following onset of 
ischemia (Table 3-1, Figure 3-1; figures and tables are located at the end of the 
I 
results section). Two minutes into the occlusion, brain temperature in 5 out of 7 
IBH animals was below 33 oc and after 3 minutes 4 of7 animals had reached 30 
°C. Skull temperature responded even more rapidly to the induced hypothermia, 
since it was in closer proximity to the cooling source. This temperature gradient 
pattern was reversed in the NBT group. In this group, the striatal temperature 
displayed a slight, non-significant decrease during the occlusion while the 
temperature at the skull, being closer to the heating source, remained virtually 
unchanged (Table 3-1). The mean occlusion temperature (brain) for the IBH 
group was 32.3 + 2.9 oc SD compared to 36.6 + 0.6 °C SD, NBT group. 
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In the early postischemic period following anaesthesia, all groups 
(including SHAM) exhibited a period of hyperthermia (Figure 3-1). The IBH 
group displayed the greatest degree of hyperthermia, which peaked at 39.1 + 0.3 
oc thirty-five minutes after ischemia and was significantly higher than both 
SHAM and NBT groups (t10 = 4.9 and t12 = 3.8, respectively, p < 0.01). This 
difference was also reflected in the rectal temperatures measured at 3 0 minutes 
postischemia (see Table 3-2). The peak brain temperature during this early 
postischemic period in the NBT group of38.5 + 0.3 °C (also 35 minutes post-
occlusion) only just reached significance compared to sham-operated controls 
(t10 = 2.3, p = 0.046). A secondary rise in brain temperature began approximately 
120 minutes post-occlusion in the NBT and IBH groups. At this time sham-
operated animals were approaching the range of normal brain temperature 
recorded two days prior to surgery, 37.4 + 0.4 oc SD. The secondary temperature 
rise observed in the ischemic groups appeared to be the result of an acute phase 
of locomotor hyperactivity which was less pronounced and recovered faster in 
the animals treated with intraischemic hypothermia (Figure 3-2). There was no 
evidence of seizures during the postischemic observation period and there were 
no fatalities in this study. 
Sham-operated animals displayed normal levels of exploration during the 
first exposure to the open field, which declined on subsequent test days (Figure 
3-3). In contrast, the animals occluded at normothermia exhibited heightened 
levels of activity during all test sessions, with little or no within session 
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habituation to the environment. However, in the group subjected to hypothermia 
no impairment was noted, except for a tendency on Day 3 to have slightly 
elevated levels of activity relative to controls. When the individual behavioural 
responses of animals within the IBH group were analyzed two main patterns 
emerged. Some hypothermic animals had open field scores that were identical to 
shams, while others closely resembled the normothermic group during the initial 
part of the session but then began to habituate in the later minutes, Figure 3-4B. 
When the day 7 open field scores of the hypothermic group were divided (based 
on day 3 behaviour) the animals with a slight deficit on day 3 started at the same 
level as the NBT group but quickly dropped down to the same level as the other 
half of the IBH group, Figure 3-5B. On the third session in the open field (day 
1 0), there was no difference in response patterns between the animals in the IBH 
group, Figure 3-6B, the entire group responded in the same manner as the sham-
operated group as indicated by the total scores in Figure 3-3. All animals 
appeared healthy on each test day, and there were no group differences in initial 
body weight or in weight assessed 7, 14 and 21 days after ischemia (Table 3-3). 
Evoked responses of CA 1 pyramidal cells to orthodromic stimulation were 
measured in all20 animals, 3 weeks postischemia. Field excitatory post-synaptic 
potentials (fEPSPs) from 55 hippocampal slices were recorded in stratum radiatum 
following stimulation of Schaffer-collateral/commissural fibers. Not surprisingly, 
in slices taken from animals in the NBT group there was a dramatic reduction of 
I 
the CA 1 response, although a presynaptic fiber volley was often recorded 
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(Figure 3-7A). The reduction in the amplitude of the maximal EPSP was 
associated with a decrease in the slope and area of the fEPSPs (Figure 3-8). 
There was also a significant change in the latency of the response, starting an 
average of2.3 ms following stimulation compared to 1.72 ms in sham-operated 
controls. However, in slices taken from animals treated with intraischemic 
hypothermia field potentials recorded in CA 1 were indistinguishable from shams. 
Histological assessment of CA 1 confmned that there was substantial cell 
loss from dorsal CAl in the NBT group at all three rostro-caudallevels (Figure 3-
9), while intraischemic hypothermia provided remarkable protection against the 5 
minute occlusion, as previously suggested by the functional measures. In both 
ischemic groups greater neuronal injury was observed at the most rostral level 
assessed (-1.7 mm) and there was no significant cell loss in ventral CAl. 
The mean brain temperatures during occlusion, of both ischemic groups 
combined, accurately predicted histological outcome 3 weeks later (level -1.7 mm; 
r = 0.98, p = 0.0001, n = 14). Within the IBH group alone this still holds true, 
I 
animals with higher mean temperatures during occlusion (probably resulting from 
a slower rate of cooling) had a greater degree of CAl damage (r = 0.78, p = 0.04, n 
= 7) but temperatures during occlusion measured at the skull were not predictive 
of eventual cell loss in this group (r = 0.07, p = 0.88). Within the NBT group, 
there was no relationship between temperature during ischemia and histological 
outcome (most likely as ~ result of the strict temperature maintenance throughout 
occlusion). For this group, variability in CAl damage scores was attributable to 
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the brain temperature during the first 90 minutes ofreperfusion (r = 0.77, p = 0.04, 
n=7). 
Each of the functional measures used in this study, assessment of open 
field activity and fEPSPs measured in stratum radiatum, correlated with the extent 
of CAl cell loss (see Table 3-4). 
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Table 3-1. Intraischemic Temperature 
Brain, skull and rectal temperature (°C) were recorded at the start of occlusion 
(S.O.) and during ischemia. Measurements for sham-operated animals were taken 
at comparable times relative to the period of anaesthesia. 
Ischemia (minutes) 
S.O. 1 2 3 4 5 
SHAM 
Brain 36.9 ± 0.6 36.9 ±0.4 36.9 ± 0.3 36.9 ± 0.3 37.0 ± 0.2 37.0 ±0.2 
Skull 37.0 ±0.6 37.0 ±0.8 37.1 ± 0.6 37.3 ± 0.5 37.2 ±0.7 37.1 ±0.9 
Rectal 37.9 ±0.2 37.8 ±0.2 37.8 ± 0.2 37.8 ± 0.3 37.8 ± 0.3 37.8 ±0.3 
NBT 
Brain 37.1 ±0.1 36.8 ±0.4 36.5 ± 0.6 36.4 ±0.7 36.3 ±0.7 36.2 ±0.5 
Skull 37.3 ±0.5 37.2 ±0.8 37.2 ± 1.0 37.2 ± 1.0 37.2 ±0.9 37.2±0.9 
Rectal 38.0 ± 0.3 38.0 ± 0.3 38.0 ± 0.3 38.0 ± 0.3 38.0 ± 0.3 38.0 ±0.2 
IBH 
Brain 37.0 ± 0.3 34.7 ±0.7 * 32.5 ± 0.8 ** 30.7 ±0.8 ** 29.6 ±0.9 ** 29.4 ± 0.7 
Skull' 37.2 ±0.7 31.4±3.5 ** 29.8 ±3.4 ** 28.7±3.3 ** 29.6 ±2.0 ** 30.2 ±2.3 
Rectal 37.9 ±0.3 37.9 ± 0.3 37.9 ± 0.2 37.8 ±0.2 37.8 ±0.2 37.7 ±0.3 
Values are the mean+ so. * p < 0.05, ** p < 0.01 post-hoc tests (Dunnett t) 
compared the sham-operated group to both ischemic groups. 
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Figure 3-1. Intra- and postischemic brain temperature 
Brain temperature recorded during ischemia/sham operations (-10 minutes to 
"'+ 10- + 15 minutes) and then following surgery in unanesthetized animals. Time 
0 indicates the initiation of ischemia, group temperatures at the end of occlusion 
are indicated 5 minutes after ischemia onset. All values are group means, for 
clarity the variance has not been indicated but the SD's ranged from 0.05 octo 
0.9 °C. For detailed temperature profiles during ischemia see Table 3-1. Open 
circles, SHAM group (n=5); solid triangles, NBT group (n=7); solid squares, IBH 
group (n=7). 
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Table 3-2. Postischemic Temperature 
Brain temperature (°C) was recorded on-line every 20 seconds in the 
postischemic period. Rectal temperature was sampled at 30 and 60 minutes after 
the end of occlusion. Measurements for sham-operated animals were taken at 
comparable times relative to the period of anaesthesia. 
Postischemia (minutes) 
30 60 120 180 
SHAM 
Brain 38.3 ± 0.4 37.9 ± 0.2 37.8 ± 0.4 37.4 ±0.6 
Rectal 36.8 ±0.5 36.5 ± 0.6 
--- ---
NBT 
Brain 38.4 + 0.4 37.6 ± 0 .5 38.8 ±0.8 38.7 + 0.6 • 
Rectal 37.3 ±0.7 36.0 ± 0.7 
--- ---
IBH 
j 
Brain 38.9 ± 0.7 38.3 ± 0.6 38.4 ±0.6 38.2 ± 0.4 
Rectal 38.3 + 0.9 • 37.2 ± 1.2 --- ---
Values are the mean+ SD. * p < 0.05, post-hoc tests (Dunnett t) compared the 
sham-operated group to both ischemic groups. 
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Figure 3-2. Postischemic brain temperature and activity counts 
Brain temperature and activity were recorded during the postischemic period 
using Mini-Mitter brain temperature probes which also record activity by 
telemetry. Brain temperature (°C) is indicated on the left axis and plotted as a 
line, activity counts are plotted as histograms with the reference scale on the right 
axis. Time 0 indicates the end of occlusion (and a comparable time relative to 
anaesthesia in the sham-operated group). All values are group means± SD, with 
the number of animals for each group indicated on the graph A, SHAM group; 
B, IBH group; C, NBT group~ Only a subset of animals continued to be 
monitored after 3 hours therefore a gap is shown on the graph to indicate that the 
second half of the recordings are not based on the total group. The number of 
animals after 3 hours varied with increasing time postischemia from the total 
group at 3 hours, to only 1 animal in the SHAM and NBT groups at 5 hours. 
Activity and temperature are averaged over 15 minute intervals. 
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Figure 3-3. Total open field scores on test days 3, 7 and 10 
Sum of the locomotor activity during a 10 minute session in a novel open field, on 
each of the three postischemic test days. Solid bars, SHAM group (n=6); hatched 
bars, NBT group (n=7); open bars, IBH group (n=7). All values are the group 
means± SEM. There was a significant treatment effect (F 2,17 = 37.812, p < 
0.0001) as a result of the heightened activity exhibited by the NBT group on all 
test days, which was significantly different from sham-operated controls (**, p < 
0.01, Dunnett t). 
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Figure 3-4. Individual group scores, per minute- Open field test day 3 
A. This graph is a minute by minute portrayal of the data from Figure 3-3, test day 
3. Values are the group means ± SD. Open circles, SHAM group (n=6); filled 
triangles, NBT group (n=7); filled squares, IBH group (n=7). 
B. The IBH group has been divided into two separate groups based on the open 
field behaviour. Squares with the bottom right corner filled are the IBH-low 
group (n=4) and these animals behaved in a similar manner as the sham-operated 
animals; squares with the top left comer filled are the IBH-high group (n=3). The 
SHAM and NBT groups have been replotted for comparison to the bimodal 
responses of the IBH group. 
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Figure 3-5. Individual group scores, per minute- Open field test day 7 
A. This graph is a minute by minute portrayal of the data from Figure 3-3, test d 
7. Values are the group means-+- SD. Open circles, SHAM group (n=6); filled 
triangles, NBT group (n=7); filled squares, IBH group (n=7). 
B. The IBH group has been divided into two separate groups based on the ope 
field behaviour on day 3. Squares with the bottom right comer filled are the IB: 
low group (n=4); squares with the top left comer filled are the IBH-high group 
(n=3). The SHAM and NBT groups have been replotted for comparison to the 
bimodal responses of the IBH group. 
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Figure 3-6. Individual group scores, per minute- Open field test day 10 
A. This graph is a minute by minute portrayal of the data from Figure 3-3, test day 
10. Values are the group means+ SD. Open circles, SHAM group (n=6); filled 
triangles, NBT group (n=7); filled squares, IBH group (n=7). 
B. The IBH group has been divided into two separate groups based on the open 
field behaviour on test day 3. Squares with the bottom right comer filled are the 
IBH-low group (n=4); squares with the top left comer filled are the IBH-high 
group (n=3). The SHAM and NBT groups displayed in (A) have been replotted. 
A. 
B . 
r::: 125 
.E 
--
-o 
Q) 
~ 100 
0 
-() 
en 
Q) 
-~ 75 
C"' 
en 
-0 
-~ 50 
E 
::::l 
z 
. 5 125 
E 
--
-o 
Q) 
~ 100 0 
-() 
en 
Q) 
-~ 75 
C"' 
en 
15 
-~ 50 E 
::::l 
z 
2 4 6 8 10 
Test Session (minutes): Day 10 
2 4 6 8 10 
Test Session (minutes): Day 10 
63 
Table 3-3. Percentage change in body weight assessed weekly following 
ischemia. 
Treatment Weight prior Weight change following ischemia(%) 
Groups to ischemia (g) 7 days 14 days 21 days 
SHAM 69.50+8.33 + 4.65 + 8.1 +4.57+4.6 + 8.13 + 8.5 
NBT 71.18+7.24 - 1.04+4.0 + 1.53 +4.5 + 2.90 + 5.1 
IBH 68.71 + 7.78 + 1.13 + 3.6 +2.23 +5.8 + 5.00+5.8 
Values are the mean+ SD. There were no significant differences in weight among 
the three treatment groups. 
64 
Figure 3-7. Representative traces of EPSPs 
Representative excitatory post-synaptic potentials recorded in the CAl dendritic 
field from septal slices in each treatment group: A, NBT; B, IBH; C, SHAM. Field 
potentials were similar in both the IBH and SHAM groups. However, 
orthodromic stimulation of CAl in a hippocampal slice from the NBT group only 
elicited a fiber volley, which represents multiple action potentials in the 
presynaptic axons. 
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Figure 3-8. Summary of amplitude, slope and area measurements 
Measurements of CAl fEPSPs recorded in stratum radiatum from 55 hippocampal 
slices (SHAM, n=16; NBT, n=19; IBH, n=20) 3 weeks postischemia. Each figure 
illustrates the group means± SD. A, fEPSP amplitude; B, fEPSP slope; C, fEPSP 
area. ANOV A indicated a significant treatment effect for all three measures (F 
2,52 = 38.97, 17.701 and 17.198, respectively; p < 0.0001) resulting from a 
reduction in the size of field potentials recorded from the NBT group (**, p < 
0.01, Dunnett t). 
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Figure 3-9. Histological assessment of CAl at three rostro-caudal levels. 
CAl cell counts were made at three levels I_X>sterior to bregma (-1.7 mm, -2.2 mm 
and -2.8 mm), the sectors of CAl that were rated are indicated by the boxes on 
the line drawings. Plotted points represent the individual scores for each animal; 
SHAM group (n=6); NBT group (n=7); IBH group (n=7). Ratings of dorsal CAl 
are indicated on the left and ventral CAl on the right. Evaluation of dorsal CAl 
at the most rostral levels (-1.7 and -2.2 mm) is based on the summed ratings from 3 
sectors (maximum score = 12). One sector was rated for the assessment of dorsal 
CAl at the most caudal level ( -2.8 mm) and both ventral levels (maximum score = 
4). There was a significant treatment effect at all dorsal levels examined (H = 
14.27, 13.80 and 12.81 for -1.7, -2.2 and -2.8, respectively; p < 0.01, Kruskal-
Wallis test) as a result of the extensive cell loss from CAl observed in animals 
subjected to ischemia at normothermia (NBT group). 
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Table 3-4. Correlation matrix. 
Variables are derived from the three assessment methods; an open field test, 
extracellular field recordings obtained from stratum radiatum in hippocampal 
slices 3 weeks after ischemia and morphological assessment of dorsal CA 1 at 
three rostro-caudallevels (distance from bregma is given in mm). 
Open Field Behaviour fEPSPs Histological Assessment 
Stratum Radiatum Dorsal CAl 
day 3 day 7 day 10 amplitude slope area -1.7 -2.2 -2.8 
Behavior 
day 3 
day 7 0.82 
day 10 0.70 0.90 
fEPSPs 
amplitpde -0.81 -0.76 -0.76 
slope 0.73 0.66 0.66 -0.93 
area -0 .68 -0 .70 -0.77 0 .87 -0.71 
CAl Rating 
-1.7 mm -0.84 -0 .90 -0.87 0.88 -0 .76 0.82 
-2.2 mm -0.83 -0.89 -0.88 0.86 -0.76 0.79 0.98 
-2.8 mm -0.78 -0.85 -0.82 0.76 -0 .66 0.72 0.93 0 .96 
In all cases, p < 0.0 1, n=20. 
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Table 3-5. Functional and histological measurements from the low and high sub-
divisions of the IBH group. 
The IBH group was divided into IBH-low and IBH-high based on the behaviour 
in the open field on Day 3. The CAl ratings and fEPSP amplitudes along with the 
total number of squares crossed on Day 3 are shown below. Values are the mean 
+ the standard deviation, the small sample size precluded statistical analysis. 
Group Day3 fEPSP Dorsal CAl Rating 
Sub-divisions Open Field Amplitude -1.7mm -2.2mm -2.8mm 
Score 
ffiH-low 629.5+68.9 2.13 + 0.2 11.25 +0.96 11.75 + 0.5 4.0+0 
(n 4) 
IBH-high 886.7+68.3 1.85 +0.44 9.0 + 1.0 10.3 + 0.58 3.67+0.58 
(n 3) 
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3.4 Discussion 
This study demonstrates that intraischemic hypothermia provides near 
complete protection of CA 1 pyramidal cells from an episode of cerebral ischemia. 
Not only was there no significant CAl cell loss 3 weeks post-occlusion if 
intraischemic hypothermia was administered, but also, typical behavioural 
impairments associated with ischemic injury were absent and CA 1 synaptic 
transmission was preserved. While other experiments have utilized behavioural 
tests in conjunction with histological assessment to demonstrate both functional 
and morphological protection, this study is unique in that electrophysiological 
measures were combined with behavioural and histological evaluations of CA 1 
I 
integrity. Functional measures of assessment can verify whether a putative 
protective treatment is efficacious. It is possible that some drug therapies, which 
appear to be protective histologically, may fail to yield functional protection 
because cells are in a transitional state from which they may or may not recover. 
Early postischemic changes in behaviour are indicative of ischemic injury. 
Following a 5 minute occlusion, animals are typically inactive initially and exhibit 
a period of "postischemic hunch'', a postural change characterized by kyphosis 
of the spine. This is reflected in Figure 3-2C, where the ischemic hunch posture 
lasted 1.5 - 2 hours in the NBT group. Following this period of inactivity, there is 
a second phase where animals become hyperactive. This behavioural activation 
I 
is discussed in more detail in Chapter 5. In the intraischemic hypothermia group 
the postischemic behavioural activity pattern was altered. The peak behavioural 
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activation occurred sooner and within 3.5 - 4 hours post-occlusion the activity 
levels had returned to control levels. 
Open field testing in this study was carried out from 3 to 10 days 
postischemia. If hypothermia had not preserved normal function, then testing 
during , this time period would be more likely to detect an impairment since 
behavioural tests should be most sensitive before any substantial recovery of 
function has taken place. No significant differences in locomotor activity were 
found between the IBH and SHAM groups exposed to a novel open field, even 
during the frrst week postischemia. However, there was a non-significant 
tendency for the IBH group to display higher levels of locomotor activity than 
the SHAM group 3 and 7 days postischemia (Figure 3-3), whereas on day 10 full 
recovery had taken place. As shown in Figure 3-4B, the trend for slightly high 
activity scores in the open field was due to the behaviour of 3 animals in the IBH 
group, referred to as the IBH-high sub-group. The NBT group displayed very 
high activity levels and a much slower rate of habituation to the environment 
over all three test sessions. These results suggest that it is important to conduct 
behavioural tests (depending on task complexity) within the first weeks after 
occlusion in order to detect functional impairments. This would be essential in 
cases of partial protection produced by any type of therapeutic intervention. 
It has previously been shown that the open field task is sensitive to 
hippocampal damage resulting from forebrain ischemia and impairments are 
unrelated to cell loss in other brain regions such as striatum (Mileson and 
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Schwartz, 1991 ). The present fmdings imply that hippocampal function is spared 
when hypothermia is administered during the five minute ischemic episode. 
Using the Morris water maze task, Green et al. (1992) have also suggested that 
intraischemic hypothermia preserves hippocampal function. However, their 
functional measure was not predictive of the histological outcome. In the 
present study both open field locomotor activity and the electrophysiological 
competence of CA 1 pyramidal cells was predictive of dorsal CA 1 cell ratings 
(Table 3-4). In Table 3-5 measurements from the functional and histological 
assessments of the two sub-divisions of the IBH group are presented. Animals 
in the IBH -high sub-group had higher activity scores in the open field on Day 3 
than the IBH-low sub-group (see also Figure 3-4B), correspondingly fEPSP 
amplitudes and CAl cell ratings were lower in the IBH-high sub-group. These 
findings reveal that the behavioural measure in the open field is able to predict 
small differences in the ultimate histological outcome (--- 84 % versus 97 % dorsal 
CAl). 
Previous studies (Buzsaki et al., 1989; Urban et al., 1989, 1990; Jensen et 
al. , 1991; Kirino et al., 1992) have utilized electrophysiological measures to study 
changes in neuronal transmission and to monitor the progression of cell death 
during. the initial hours and days after an ischemic event. To the best of our 
knowledge this is the frrst report using extracellular recording techniques several 
weeks after occlusion to demonstrate that a putative therapy for ischemic injury 
has preserved normal synaptic function in the CA 1 region. Measuring the 
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physiological properties of CA 1 neurons has the advantage that recovery of 
function and compensatory mechanisms arising from extra-hippocampal brain 
structures which help reduce behavioural deficits several weeks after ischemia do 
not interfere with the direct functional assessment of CA 1. Field responses 
recorded in stratum radiatum from the IBH group were similar to those from 
SHAM controls on measures of amplitude, area and slope. Again, as seen with 
early behavioural testing, there was a slight trend for the size of the CA 1 field 
potentials to be reduced in the IBH group versus SHAM controls (see Fig. 4A). 
This slight reduction in field potential size most likely reflects a small loss of CA 1 
neurons in some animals which is consistent with the morphological outcome 
(i.e. the IBH-high group). Within the NBT group, there was a noticeable 
variation in response depending on where the slice had been taken along the 
septo-temporal axis of the hippocampus. Field responses in the majority of NBT 
slices were severely attenuated or completely absent. However, some temporal 
slices which correspond to the more ventral aspect of the hippocampus had 
much larger fEPSPs that in a few cases were near normal in size. These 
differences between dorsal and ventral CA 1 were also observed in the 
histological assessment. 
The single most important determinant of CA 1 injury in this study was the 
brain temperature during occlusion. This was most obvious within the IBH 
group because of .a greater range in intraischemic brain temperatures. When CA 1 
ratings for this group were compared to minute by minute brain temperatures 
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throughout the period of ischemia it was found that only one time point was 
predictive of histological outcome. The critical factor which determined whether 
an animal would have total or near total protection was the brain temperature 3 
minutes into the occlusion (r = 0.87, p < 0.01, n = 7). Both in vitro and in vivo 
ischemia models have independently shown that 2.5- 3 minutes appears to be a 
threshold point below which no permanent injury occurs, but beyond this time 
CAl neurons are irreversibly damaged (Nowak et al., 1985; Kato et al., 1989; 
Raley and Lipton, 1990; Andou et al., 1992). Within the IBH group, the least 
protection ( -1.7 mm: rating scores 8/12 and 9/12) was found in animals that had 
the highest brain temperatures following 3 minutes of ischemia (31.9 oc and 31.8 
°C, respectively). Whereas the two animals with complete protection ( -1.7 mm: 
rating scores 12/12) had the lowest brain temperatures at this time, 30.1 oc and 
30.0 °C. Thus, complete protection against a 5 minute occlusion could be 
obtained if the brain temperature was cooled to a sufficient level before the three 
minute threshold point was crossed. Interestingly, Raley and Lipton ( 1990) have 
shown that hippocampal slices subjected to in vitro "ischemia'' for 2 minutes will 
quickly recover protein synthesis to normal levels, whereas such treatment for a 
duration of 5 minutes will result in an extended period of protein synthesis 
inhibition. Intraischemic hypothermia, in vivo, may exert its protective action by 
preventing the pathogenesis which occurs after 2.5- 3 minutes of ischemia thus 
allowing recovery of protein synthesis and normal neuronal function (see 
Widmann et al., 1993). In addition to the importance ofintraischemic brain 
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temperature, postischemic temperature can also influence outcome. As seen in 
the NBT group, small variations in brain temperature during the first 90 minutes 
of reperfusion had significant effects on both functional and histological 
outcome. 
A question raised by the present data is whether intraischemic 
hypothermia provides permanent neuroprotection. Some of the animals treated 
with intraischemic hypothermia may not have complete protection as evidenced 
by the observed trend for this group to display small, non-significant deficits in 
comparison to sham-operated controls on all three assessments. However, these 
slight differences were apparent within the frrst week after ischemia and were not 
exacerbated over time as would be expected if cell loss was continuing beyond 7 
days post-occlusion. In addition to histological outcome, the 
electrophysiological recordings made 3 weeks postischemia indicated that 
synaptic transmission was normal which is suggestive of permanent protection 
of CAl neurons. Consistent with our findings, Dietrich et al. (1993) have shown 
that when the brain is cooled to 30 oc during the period of ischemia histological 
protection is still observed 2 months later. Permanent functional as well as 
histological protection, resulting from hypothermic intervention during ischemia 
has also been demonstrated by Green and colleagues ( 1992) in a rat model of 
global ischemia. 
'In this study, open field behaviour and extracellular field recordings 
evoked in the CAl dendritic field both predicted histological outcome. The 
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functional measures correlated significantly with each other and with dorsal CA 1 
ratings. It would seem that any one of these measures alone could adequately 
determine outcome following ischemia. However, this consistent relationship 
between all three outcome measures may only exist when a treatment has 
provided lasting neuroprotection. For example, other treatments such as drug 
therapy or postischemic hypothermia may not provide chronic protection, but 
only delay cell death (Dietrich et al., 1993; Colbourne and Corbett, 1994a ). In 
view of these considerations it would seem advantageous to combine 
histopathological assessment with functional assessments using long survival 
times (e.g. at least several weeks). This approach could provide a more accurate 
indication of the viability of hippocampal neurons, particularly in 
pharmacological studies such as the next experiment. 
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4.1 Introduction 
Delayed cell death resulting from cerebral ischemia is thought to be 
ultimately due to an excessive rise in free Ca2+ within vulnerable neurons, 
triggered by the excitatory neurotransmitter glutamate (Choi, 1988; Siesjo and 
Bengtsson, 1989). Initial optimism that NMDA receptor antagonists might be 
effective in treating stroke (Gillet al., 1987) has been tempered by the fmding that 
the most potent of these compounds, MK-801, produced its neuroprotective 
action by inducing hypothermia (Buchan and Pulsinelli, 1990; Corbett et al., 1990; 
Nellgard et al., 1991). More recently, the AMPA antagonist, NBQX, was reported 
to provide robust protection against neuronal loss in several animal models, even 
with postischemic treatment (Sheardown et al., 1990; Buchan et al., 1991a; Diemer 
et al., 1992; Nellgard and Wieloch, 1992; Sheardown et al., 1993). Accordingly, it 
has been concluded that the AMP A receptor has a greater involvement in global 
ischemic injury than the NMDA receptor and stroke trials with AMP A receptor 
antagonists have been suggested (Buchan et al., 1993). 
In the majority of studies in which NBQX has provided protection, however, 
temperature was not controlled during the postischemic period (Sheardown et al., 
1990; Diemer et al., 1992; Sheardown et al., 1993). In view of the fact that many 
pharmacological studies of cerebral ischemia have been confounded by drug-
induced hypothermia, it is essential that putative neuroprotective agents are 
examined closely to rule out similar interactions with brain temperature. In 
addition, recent data suggest that the preservation of CA 1 neurons by several 
postischemic treatments may not be permanent (Morse and Davis, 1990; Dietrich 
et al., 1993; Colbourne and Corbett, 1994a). Since most pharmacological studies, 
81 
including those with NBQX, have utilized short survival times ( 1 week or less), 
the protection observed with this drug may also be transitory. 
Although it has been reported that NBQX does not affect temperature 
(Sheardown et al., 1990), a significant decrease in temperature following NBQX 
administration has been noted when temperature has been monitored for 
prolonged periods (Suga and Nowak, 1992; Nurse and Corbett, 1993). Using the 
gerbil 2-vessel occlusion model, the postischemic temperature profiles of animals 
treated with NBQX were compared to those of vehicle controls. In order to 
determine if hypothermia contributed to the beneficial effect of NBQX a third 
group was given NBQX but their temperature was regulated from 1 to 24 hours 
postischemia, so that it mimicked the pattern in vehicle treated animals. In a 
second experiment, the NBQX temperature profile was simulated in the absence 
of drug treatment and the histological outcome was compared to that of NBQX 
treated gerbils at survival times of 4 and 10 days. 
4.2 Methods 
4.2.1 Brain Tern perature Monitoring 
Brain temperature was recorded on-line from AM-transmitter probes inserted 
through a guide-cannula into the dorsal striatum, as described in section 2.2. 
Two days prior to the administration ofNBQX or induction of ischemia, baseline 
temperature was recorded for 3 hours in order to ensure readings were within the 
normal range. The sampling rate for all temperature recordings was 3/minute. 
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4.2.2 Temperature Effects ofNBQX in Normal Animals 
Two rodent species commonly used in models of ischemia, Sprague-Dawley 
rats (n = 4) and gerbils (n = 5), were examined for their temperature response to 
NBQX. Two days after initial temperature recording (see 4.2.1), temperature 
probes were reinserted into the guide-cannula. Following baseline recording for 
1 hour, NBQX was administered as three separate intraperitoneal injections (3 x 
30 mg/kg, i.p.). Injections were spaced 15 minutes apart. The drug was dissolved 
in NaOH (0.1 M) and diluted in 5.5% glucose, final pH was 8.5 + 0.1. Brain 
temperature was monitored for 24 hours. One gram ofNBQX (NNC 07-9202 acid) 
was dqnated by Novo-Nordisk, Copenhagen. All subsequent experiments used 
gerbils only. 
4.2.3 Cerebral Ischemia 
Gerbils were anaesthetized with 2% halothane in 30% 02/70% N20 and 
maintained at 1.5% throughout the operative procedure. The carotid arteries 
were isolated and occluded for 3 minutes at normothermia, as described in 
section 2.3. Sham-operated animals (n = 3) underwent carotid isolation without 
ischemia. Brain temperature continued to be monitored postischemically in 
unanaesthetized animals for up to 3 0 hours. During the initial 60 minutes of 
reperfusion, a 60 watt lamp was used to maintain normothermia (---- 3 7 °C), if 
necessary. Mild postischemic hyperthermia, which occurs spontaneously, was 
not prevented. 
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Experiment!. 
Animals received either vehicle (5.5% glucose, pH 8.5, n = 7) or NBQX (30 
mg/kg, i.p., n = 16) at 60, 75 and 90 minutes postischemia. NBQX treated animals 
I 
were subdivided into two groups (n = 8 per group): NBQX and NBQX 
(regulated). Temperature regulation was discontinued in all groups 60 minutes 
after the occlusion, except the NBQX (regulated) group. In the NBQX (regulated) 
group the brain temperature was maintained at the same level observed in the 
vehicle treated group using an overhead lamp, with a variable height adjustment, 
until 24 hours post-occlusion. Following the period of temperature recording (24 
- 30 hours), temperature probes were removed and the animals were returned to 
their home cages. Behavioural testing in the open field was conducted on days 
3, 7 and 10. Following the last open field session the animals were given a lethal 
injection of barbiturate and perfused (see section 2.6). 
Experiinent II. 
The above experiments were repeated to assess vehicle (n = 6) and NBQX 
(no temperature regulation, n = 9) treatments at a survival time of 4 days. A third 
treatment group was also added, simulating the NBQX-induced temperature 
profile in the absence of drug treatment (SimTP). The NBQX-induced 
temperature profile was simulated manually (SimTP) for 28 hours postischemia 
using (1) a fan placed above the cage and/or spraying room temperature water on 
the animal's back to lower temperature; (2) turning off the fan and/or using a 60 
watt lamp to elev~te temperature. Animals in the Sim TP group had survival times 
of 4 days (n = 7) and 10 days (n = 10). Assistance with temperature regulation 
was provided by Suzanne Evans, Kathleen McKay and Dale Corbett. 
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Five additional animals were employed for electrophysiological recording 4 
days postischemia. Two animals were occluded for 3 minutes and given NBQX 
(3 x 30 mg/kg) 1 hour postischemia. Two animals were implanted with a guide 
cannula for temperature recording, but did not have ischemia surgery. Brain 
probes were reinserted 2 days after baseline temperature recording and the 
animals placed in the recording boxes on AM receivers. After acquiring an hour 
of baseline data they were injected with the same dose ofNBQX as the ischemic 
animals received. This group was used as a control for the long-lasting effects of 
NBQX and the possible toxicity of this compound with respect to hippocampal 
field potentials. A fifth animal was occluded for 3 minutes and then sacrificed for 
electrophysiology at the same time point as the other animals, 4 days 
postischemia/injection. This animal did not receive NBQX. 
4.2.4 Histological Analysis 
At either 4 or 10 days postischemia, animals received an overdose of sodium 
pentobarbital prior to perfusion fixation. Brain tissue was placed in 10% 
phosphate-buffered formalin (pH 7.4) overnight, in situ. The following day, the 
brain was extracted from the skull and stored in the same fixative. Blocks were 
dehydrated and embedded in paraffin. Sections were cut at 6 J..Lm and 
subsequently stained with haematoxylin and eosin. Some of the histological 
processing was done by Suzanne Evans and Kathleen McKay. Three sectors in 
dorsal CA 1 (lateral, middle and medial) were counted in each hemisphere at a 
level 1. 7 mm posterior to bregma. Cell counts were performed by Dale Corbett 
who was blind to the treatment status of the animals. The six sectors were then 
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summ~d to yield a total CAl score. CAl cell counts from six control animals were 
pooled with the 3 sham-operated animals to provide an assessment of 
uninjured/control CAl. 
4.2.5 Statistical Analysis 
Total CAl scores were analyzed with ANOVA, followed by Student-
Newman-Keuls post hoc comparisons. 
4.3 Results 
When NBQX (3 x 30 mg/kg, i.p.) was given to non-ischemic animals (Figure 
4-1), there was an initial drop in brain temperature of2.0 oc in gerbils and 3.5 oc in 
rats. Three to 5 hours following drug administration, temperature partially 
recovered, but remained below the control level for longer than 24 hours. The 
changes recorded in brain temperature were also reflected in rectal temperature, 
which was sampled periodically in some animals (data not shown). 
With postischemic NBQX administration, in the unregulated condition 
(Figure 4-2D), there was also an-- 2 oc decrease in brain temperature below that 
observed in the vehicle treated group (Figure 4-2B). The NBQX temperature 
profile was altered by ischemia (compare Figure 4-lA and Figure 4- 2D). During 
ischemia and the initial 2 hours of reperfusion, the brain temperatures of NBQX 
(Figure 4-2D) and vehicle (Figure 4-2B) groups were not different. Thereafter, the 
tempe:r:ature ofNBQX treated animals was significantly reduced, 1.0 to 2.0 °C, 
with a maximal difference(-- 2.0 °C) evident 2.5- 3 hours postischemia. Beginning 
3 hours postischemia, the temperature gradually declined in both the NBQX and 
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vehicle treated groups, leveling off.-.- 1.5 oc below the starting point at 15 hours 
postischemia. The slopes of the temperature profiles in the NBQX and vehicle 
treated groups were similar, with the NBQX group temperature profile being 
shifted 1.0- 1.5 oc below the vehicle group. The brain temperature in the NBQX 
group was stilll.O- 1.5 oc lower at 30 hours postischemia (Figure 4-2D). In an 
' 
additional group treated with NBQX, brain temperature was manually regulated 
until 24 hours postischemia (Figure 4-2C) to prevent the drug-induced decrease 
in temperature. Interestingly, within 15 minutes following the termination of 
temperature regulation in this group (i.e . .-.- 24 hours post-occlusion), brain 
temperature felll.O oc and remained 1.0- 1.5 oc below the vehicle group until the 
end of the recording session (Figure 4-2C). This new temperature was similar to 
the temperature recorded in the NBQX, non-regulated, group at this time (Figure 
4-2D). 
The mean CA 1 cell counts and standard deviations for the three treatment 
groups: NBQX; NBQX regulated and untreated ischemic animals were: 218.5 + 
66.15; 62 + 32.33 and 59.21 + 57.18, respectively. Virtually all of the variance in 
histological outcome was attributable to the mild differences observed in 
postischemic brain temperature during the initial 24 hours of reperfusion. The 
number of viable CA 1 neurons was inversely related to the mean brain 
temperature from 0 - 24 hours postischemia (Figure 4-3). ANOV A of the total 
CAl cell counts for normal, vehicle, NBQX and NBQX (regulated) groups 
(Experiment I) yielded a significant treatment effect (p < 0.0001). Post hoc 
comparisons of total CA 1 counts revealed that the NBQX group had a 
significantly improved histological outcome compared to both the NBQX 
(regulated) and vehicle groups (p < 0.01). However, the NBQX group did exhibit 
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a significant degree of cell loss in comparison to controls (p < 0.01). There was 
no statistically significant histological protection achieved with the same dose of 
NBQX when mild hypothermia was prevented by regulating brain temperature for 
24 hours (see Figure 4-3). 
When protection obtained with NBQX was compared to the level of 
protection obtained with a 28 hour temperature simulation (Figure 4-2E, 
Experiment II) it was found that both NBQX and the SimTP treatment produced 
substantial savings of CA 1 neurons. These groups were not significantly 
different when histological assessment was made 4 days postischemically 
(Figure 4-4 ). Histological protection with both treatments, at 4 and 10 days 
. 
postischemia, was significantly better than vehicle (p < 0. 0 1 in all cases, except 
SimTP versus vehicle (10 day survival) p < 0.05). 
Electrophysiological recordings from CAl in hippocampal slices revealed 
a slight tendency for slices obtained from NBQX treated animals to have smaller 
field potentials 4 days after occlusion (Figure 4-5). The EPSP slope was 
significantly reduced, but the amplitude and area measurements did not reach 
significance. Field potentials recorded from the CA 1 region in slices from an 
animal who had a 3 minute occlusion, but no treatment intervention, were 
severely attenuated at 4 days postischemia. The NBQX treatment in animals not 
receiving an ischemic insult did not appear to have any effect on the field 
potential. 
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Figure 4-1. Twenty-four hour temperature record of gerbils and rats given NBQX 
(3 x 30 mg/kg), but not receiving ischemia. 
NBQX (3 x 30 mg/kg, i. p.) was administered to gerbils (A) and rats (B) 
starting 1 hour after the initiation of brain temperature recording. The arrow 
indicates the time of the first injection, the second and third injections were 15 
minutes and 30 minutes later, respectively. The temperature profiles in each graph 
represent group means, with the shaded area depicting one standard deviation 
above and below the mean. Temperature data have been averaged over 10 
minute intervals. The mean baseline brain temperature is indicated by the dashed 
line. 
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Figure 4-2. Brain temperature following ischemia/sham surgery. 
Brain temperature (°C) is plotted with time 0 representing the beginning of 
reperfusion. The profiles are group means for each treatment, the standard 
deviation above and below the line is shown by the shaded area. The dashed line 
on each graph indicates mean control brain temperature (36.9 °C). Vehicle (3 X 
5.5% glucose, i.p.) and NBQX injections (3 x 30 mg/kg, i.p.) were given starting 
60 minutes after ischemia, each injection separated by 15 minutes. The heavy bar 
along the x-axis indicates the duration of postischemic temperature control, 
which was 60 minutes in all groups except C and E (see methods section 4.3.3: 
Experiment I and Experiment II). Note the drop in brain temperature in the 
NBQX (regulated) group at the end of temperature maintenance (C). All 
temperature data have been averaged over 10 minute intervals. 
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Figure 4-3. Scattergram of postischemic brain temperature and CAl cell counts. 
Relationship between postischemic brain temperature (averaged from 0 to 24 
hours post-occlusion) and the number of viable CAl neurons, r ==- 0.901, df == 22, 
p < 0.0001. Histological assessment was made 10 days after ischemia. Vehicle 
treated animals (open circles), n == 7; NBQX (3 x 30 mg/kg i.p., open triangles), n == 
8; NBQX with brain temperature regulated for 24 hours to mimic the pattern in 
the vehicle group (solid triangles), n == 8. 
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Figure 4-4. Histological outcome following treatment with NBQX at 4 and 10 
day survival times. 
Percentage of CAl neurons surviving 4 versus 10 days postischemia. CAl cell 
counts are expressed as a percentage of control (290.11 ± 13.72 SD; n = 9). All 
groups had a 3 minute carotid artery occlusion with either NBQX (30 mg/kg i.p., 
60, 75 and 90 minutes postischemia); temperature simulation to resemble the 
NBQX treated group for 28 hours postischemia (SimTP); or 5.5% glucose vehicle 
(60, 75 and 90 minutes postischemia). Error bars indicate the standard deviation 
(6 to 10 animals/group);* p < 0.05, ** p < 0.01 in comparison to vehicle 
treatment. 
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Figure 4-5. Electrophysiological measures from slices taken 4 days after 
treatment with NBQX. 
CAl fEPSPs were recorded from 18 hippxampal slices. Ischemic animals (7 
slices, n=2) were given NBQX (3 x 30 mg/kg) 1 hour postischemia. Control 
animals (7 slices; n = 2) were also administered NBQX (3 x 30 mg/kg). Both 
groups were tested 4 days after ischemia/drug-injections. Slices from an animal 
occluded for 3 minutes, but not treated postischemically (4 slices, n=l), were also 
examined to verify that the CAl fEPSPs were virtually absent by 4 days after 
ischemia when no intervention was given. A, amplitude; B, slope; C, area. There 
was a significant treatment effect for all three measures F 2,15 = 13.528, 9.760, 
11.601, respectively; p < 0.01. 
* p < 0.05, ** p < 0.01 Dunnett test. 
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Figure 4-6. Extended brain temperature recordings following postischemic 
treatment with NBQX. 
Brain temperature recorded postischemically for 1 week following NBQX 
treatment (3 x 30 mg/kg, i.p.) administered at 60, 75 and 90 minutes postischemia 
(time 0 is the start of reperfusion). The shaded area represents the standard 
deviation above and below the mean. Temperature data have been averaged 
over 30 minute intervals. The dashed line indicates mean control brain 
temperature (36. 9 °C). 
..-.. 
39 
0 NBQX (n=7) 
0 
...._.. 
(I) 37 
'-
::::J 
... 
m 
'-(I) 
c. j 35 
E (I) 
1-
s::: 33 
·-m 
'-m 
0 1 2 3 4 5 6 7 
Time (days) 
100 
4.4 Discussion 
The results show that a dose ofNBQX (3 x 30 mg/kg) which has previously 
been reported to be beneficial against ischemic injury (Sheardown et al., 1990; 
Buchan et al., 1991a; Diemer et al., 1992), has a mild hypothermic action that is 
linearly related to its neuroprotective efficacy. NBQX was not protective against 
injury following cerebral ischemia when the temperature was regulated to mimic 
that of the vehicle group. Furthermore, simulating the temperature profile 
induced by NBQX is sufficient to produce histological preservation of CAl cells. 
However, there was a significant decline in the protection provided by the SimTP 
treatment between 4 and 10 days postischemia (p < 0. 0 1). A similar trend of 
decreasing efficacy was also observed with NBQX. While not significant, this 
trend suggests that necrosis may progress if the survival time is lengthened to 
several weeks. While it remains possible that NBQX conveys a neuroprotective 
effect independent of temperature, it is likely that the protection provided by the 
Sim TP treatment decayed at a faster rate than that of NBQX because the duration 
of mild hypothermia was shorter. In the present study, the brain temperature of 
the SimTP group was rewarmed at 28 hours after ischemia. However, it is evident 
that NBQX treated animals were still subnormal30 hours postischemically 
(Figure 4-2E versus 4-2D). Subsequently, brain temperature was recorded for 
extended periods (up to 8 days) in animals treated with NBQX (n = 7). NBQX 
induced a state of mild hypothermia which lasted for ~ 4 - 5 days (Figure 4-5), 
thus iricreasing the period of mild hypothermia by at least 68 hours in 
comparison to the SimTP group. The long-lasting nature of this hypothermia 
may be due to a lingering precipitate of NBQX that is found in the intraperitoneal 
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cavity (Le Peillet et al., 1992; Buchan et al., 1993) and internal organs, such as the 
gall bladder, days to weeks after i.p. administration (unpublished observations). 
This precipitate might act as a depot, providing sustained release ofNBQX in 
high enough concentrations to produce a hypothermic action for several days. 
Alternatively, the toxicity of the compound alone (Aoki et al., 1994; Xue et al., 
1994) could explain its hypothermic action since non-specific drug toxicity can 
induce hypothermia (Gordon et al., 1988). In order to achieve identical 
histological protection by simulating NBQX-induced hypothermia, the simulation 
period may also have to be extended to several days. This was not possible in 
the present study because temperature was controlled manually and maintaining 
temperature at a slightly hypothermic level required constant attention (i.e. 
monitoring the temperature every 20 seconds and making adjustments every 
couple of minutes). 
Recent tmdings from our laboratory (Colbourne and Corbett, 1994a) have 
shown that 12 hours of moderate hypothermia (32 °C) produced substantially 
less protection than 24 hours of hypothermia. The shorter duration of 
hypothermia resulted in a profound decline in protective efficacy between 10 and 
30 day survival times. It seems that within limits, increasing either the degree or 
the duration of hypothermia should improve histological outcome. Nevertheless, 
the present results suggest that mild postischemic hypothermia, may not 
transla~e to permanent neuroprotection even if the duration of hypothermia is 
prolonged (i.e. several days). 
In studies where survival times have been increased from 7 days to 1 month, 
neuroprotection with NBQX (3 x 30 mg/kg) is not maintained (Li and Buchan, 
1995). The cascade of events resulting in neuronal necrosis may only be 
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temporarily interrupted during the postischemic hypothermic period. Once 
temperature is normalized these processes may resume, albeit at a slower rate. In 
the pr~sent study, and others (see Sheardown et al., 1990), where NBQX has 
been assessed following survival times of only 4 days, histological protection is 
often indistinguishable from cell counts/ratings from control animals. According 
to the findings presented here, the animals would have still been mildly 
hypothermic at this time, which could account for the near total histological 
preservation. However, in electrophysiological recordings from slices obtained 
from animals treated with NBQX 1 hour postischemia and surviving 4 days, the 
field responses tended to be smaller than control animals treated with NBQX. 
This direct measure of CAl integrity suggests that while the histological 
appearance of the neurons is unchanged on day 4, synaptic responses are 
abnormal. However, this conclusion is tempered by the small group size in these 
experiments. The CA 1 neurons might be in a transition state from which they will 
. 
recover. However, the trend for cell loss to progress between the 4 and 10 day 
survival times and the results of Li and Buchan (1995) suggest that the possible 
impairment in electrophysiological functioning at day 4 is an indication that these 
cells are compromised and will eventually die. Treatments that provide 
apparently permanent protection, such as intraischemic hypothermia, do not 
result in reduced ·field potentials on day 4 (unpublished observations). 
Data from the open field test were also collected from all animals in the 
NBQX study. Unfortunately, the behavioural responses cannot be compared to 
the electrophysiological data because of the confounding effects NBQX had on 
behaviour. Many animals lost a considerable amount of weight following 
treatment with NBQX and the locomotor activity in the open field was very 
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inconsistent in the groups treated with NBQX. This could be a result of toxic 
effects of the drug (Aoki et al., 1994; Xue et al., 1994) and/or the long-lasting 
pharmacological blockade of the AMP A receptor. In earlier studies using the 
non-competitive glutamate receptor antagonist MK-801 we found that the drug 
had a long-lasting pharmacological action which confounded the open field 
activity scores, and as with NBQX, the behavioural data could not be used. To 
circumvent this problem we changed the timing of our frrst open field test from 1 
day after ischemia to 3 days postischemia. Unfortunately, with NBQX, 72 hours 
is obviously not long enough for the elimination of the drug and/ or recovery 
from lingering toxicity. Due to a limited availability of the drug (1 gram), it was 
not possible to evaluate the level of behavioural protection provided by NBQX 
or long term (1month) electrophysiological and histological assessments as was 
originally intended. However, as stated above, the protection provided by 
NBQX declines with increased survival time (Li and Buchan, 1995). 
Although the majority of the previous studies using NBQX have not 
regulated temperature during the postischemic period, a study by Buchan et al. 
(1991a) reported significant histological savings at 7 days when body 
temperature was regulated postischemically for 6- 8 hours. However, as shown 
in Figure 2C, the temperature of NBQX treated animals drops almost immediately 
even when temperature regulation is terminated as late as 24 hours post-
occlusion. It is also noteworthy that animals treated with NBQX demonstrate 
hypothermia even when they recover from the mild sedating effects of the drug 
and begin to show ambulation. Recovery of locomotion is often used as a marker 
of an animal's ability to thermoregulate after ischemia and a point at which 
temperature control is typically stopped. This is clearly an incorrect assumption. 
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Since NBQX administration can be delayed for 6, 12 or even 24 hours 
postischemia and still provide neuroprotection (Li and Buchan, 1993; Nurse and 
Corbett, 1993; Sheardown et al., 1993), then postischemic temperature regulation 
for less than 24 hours is likely insufficient if neuronal protection is due to 
hypothermia. The severity of the ischemia will probably determine the length of 
time that is necessary to regulate postischemic temperature and prevent 
hypothermia from confounding histological outcome. For example, following 5 
minutes of ischemia, which produces > 95 % CA 1 cell loss in our model, we have 
found NBQX treatment to be ineffective if administration is delayed until 6 hours 
after reperfusion (Nurse and Corbett, 1993). Therefore, with severe ischemia if 
NBQX is given within the first few hours of reperfusion then a 6 - 8 hour period 
of temperature regulation would probably suffice. However, after 3 minutes of 
ischemia which produces ~ 85 % CA 1 neuronal loss in our model, treatment can 
be delayed for at least 6 hours and still provide histological protection (data not 
shown). However, the protection is correlated with the level of hypothermia 
induced and no histological protection is found following the 6 hour delayed 
administration if temperature is regulated from 6 to 24 hours postischemia (Nurse 
and Corbett, 1993). In models where CAl cell loss is~ 80% or less (Sheardown 
et al., 1993), temperature regulation may need to be continued beyond 24 hours in 
order to prevent a confounding effect of hypothermia. 
The present study also helps to reconcile some of the discrepancies 
between in vivo and cell culture models of ischemia and glutamate toxicity. 
Many fn vivo studies comparing the efficacy of NMDA and AMP A receptor 
antagonists in global ischemia have found AMP A antagonists to offer 
considerably greater levels ofneuroprotection (Nellgard and Wieloch, 1992; 
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Buchan et al., 1993; Sheardown et al., 1993; Lippert et al. , 1994). Cell culture 
studies have either found no neuroprotective effects with AMP A antagonists 
alone (Kaku et al., 1991 ), or in cases where AMP A antagonists were effective the 
protection was not as great as that provided by NMDA antagonists (Lippert et 
al., 1994). However, both in vitro (Shuaib et al., 1993; Bruno et al., 1994) and in 
' 
vivo (Busto et al., 1987; Dietrich et al., 1993; Coimbra and Wieloch, 1994; 
Colbourne and Corbett, 1994a,b; Nurse and Corbett, 1994; Colbourne and 
Corbett, 1995) studies have demonstrated dramatic protection with hypothermia. 
It is important to emphasize that the level of postischemic hypothermia induced 
by NBQX is milder than that in previous studies (Busto et al., 1989; Dietrich et al., 
1993; Coimbra and Wieloch, 1994; Colbourne and Corbett, 1994a, 1995) using 
deliberate hypothermic manipulations (e.g. 32 - 34 °C). These results 
demonstrate the necessity of careful postischemic temperature assessment in 
pharmacological studies of cerebral ischemia since differences of only 1.0- 2.0 
°C, if prolonged, can significantly affect outcome. Further, the present study 
raises important questions about the wisdom of conducting costly clinical trials 
based upon current drug studies which are likely confounded by similar 
temperature effects and short survival times. 
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CHAPTERS: 
ACUTE AND CHRONIC LOCOMOTOR PATTERNS 
AS PREDICTORS OF ISCHEMIC OUTCOME 
5.1 Introduction 
The brain injury resulting from both global and focal ischemia produces 
changes in behaviour and/ or impairments in normal function. Generally, the 
deficit observed corresponds to the brain region(s) affected by the ischemia. 
Damage to the hippocampus results in memory impairments and damage to the 
motor cortex leads to paralysis or weakness. In humans, ischemia often results in 
emotional lability and cognitive deficits (Walker et al., 1981; Zola-Morgan et al., 
1986), as well as impairments in sensory and motor ability. In animal models of 
ischemia, changes such as hyperexcitability on handling (Smith et al., 1984a), 
increased startle (Truong et al., 1994), heightened locomotor activity (Chandler et 
al., 1985a; Poignet et al., 1989) and impaired performance on a number of tasks 
including the T -maze, radial arm maze, Morris water maze and passive avoidance 
have been reported (Volpe et al., 1984; Auer et al., 1989; Himori et al., 1990; 
Imamura et al., 1991; Karasawa et al., 1994). 
One of the most frequently used behavioural signs of ischemic injury in 
the gerbil 2 vessel-occlusion model has been an increase in locomotor activity. 
However, there has been confusion in the literature as to how long this 
phenomenon lasts, with reports ranging from hours to months (Gerhardt and 
Boast, '1988; Kuroiwa et al., 1991a,b; Mileson and Schwartz, 1991; Babcock et al., 
1993; Colbourne and Corbett, 1994a; Nurse and Corbett, 1994; Colbourne and 
Corbett, 1995). Our research group has recently reported that increased 
locomotion in an open field maze persists as long as 6 months after ischemia 
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(Colbourne and Corbett, 1994b). An explanation for these discrepancies can be 
found by analyzing the testing procedures used in the above experiments. In 
cases where the animals are tested in familiar environments (e.g. home cages), 
I 
increases in locomotor activity are short-lived. However, if animals are tested in 
a novel environment, then locomotor changes can persist for months, depending 
on the frequency of exposure to the environment. The different testing 
procedures, which utilize novel versus familiar environments, may reveal two 
distinct functional abnormalities, an acute change that is apparent soon after 
ischemia and a chronic change that is triggered by novelty. Both acute and 
chronic changes in locomotor activity are thought to arise from hippocampal 
injury, specifically, damage to the CAl subfield of Ammon's hom (Gerhardt and 
Boast, 1988; Wang and Corbett, 1990; Kuroiwa et al., 1991a,b; Mileson and 
Schwartz, 1991; Babcock et al., 1993). 
I 
In studies conducted over the last three years, there have been several 
interesting behavioural changes that have been noted following different 
ischemic conditions, such as occlusion duration and intraischemic brain 
temperature. The data reported in this chapter have been collected in different 
experiments and the results have been pooled in order to describe acute and 
chronic activity patterns induced by ischemia. These activity changes have not 
been well described in the literature and as a result there has been considerable 
confusion arising from conflicting results reported by different research groups 
(see Karasawa et al., 1994). Also, the value of the postischemic activity patterns 
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in predicting the degree of ischemic damage has not been appreciated by many 
researchers. In the following description of postischemic activity changes, 
measurements were made both in an environment the animals had been 
habituated to before the ischemic episode and an environment (i.e. open field) 
that was novel. The acute and chronic postischemic behavioural responses were 
compared following 1.5, 3.0 or 5.0 minute ischemic episodes, as well as under 
conditions of intraischemic hyperthermia and hypothermia. 
5.2 Methods 
All animals were prepared for brain temperature measurement as described 
in the general methods (section 2.2). Two days after cannula implantation, brain 
probes were inserted to monitor baseline temperature and activity for 
approximately 3 hours. During this three hour period, the animals were placed in 
plastic cages, measuring 21.0 x 15.2 x 18.5 em, which they had not been exposed 
to befqre. These same cages were used to house the animals again in the early 
postischemic phase. All animals habituated to this environment very quickly and 
after the initial 30 - 45 minutes they usually spent the remainder of the 3 hour 
session sleeping/resting, with intermittent bouts of activity. At the end of the 
recording session, the brain probes were removed (under halothane anaesthesia) 
and the animals returned to the animal room. 
Two days after the habituation session, cerebral ischemia or sham surgery 
was performed. In animals receiving an ischemic episode, the carotid arteries 
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were clamped for either 1.5, 3.0 or 5.0 minutes. Both rectal and brain temperature 
were monitored and maintained at normothermia throughout surgery (except in 
cases of hypo- and hyperthermic ischemia), as described in the general methods 
section. When intraischemic hyperthermia (3 8 °C) was induced, the brain 
temperature was raised to 3 8 oc before the initiation of ischemia and then kept at 
this level throughout the occlusion. When hypothermia was induced, the 
occlusion was started while brain and rectal temperatures were normothermic. 
Once the arterial clamps were applied, as described in the general methods 
(section 2.3), then the brain temperature was quickly cooled. Following surgery 
I 
the anaesthestic nose cone and heating blankets were removed. The animals 
were placed on AM receivers in the plastic cages they had previously been 
habituated to, with the telemetry brain probe still in place. All postischemic brain 
temperature/activity measurements were made while the animal was in this 
environment. Following the acute postischemic monitoring period, animals were 
put back into their home cages and returned to the animal room. 
Measurement of locomotor activity in a novel open field was initiated 3 
days post-occlusion/sham surgery. The 10 minute test sessions were carried out 
in a sound attenuated room. After placing the animal on the floor of the maze 
and starting computerized data collection, the experimenter left the room. The 
animal's behaviour could be observed through a small window (31 x 31 em). The 
computerized tracking system monitored the number of squares crossed during 
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each minute of the test session. Depending on the survival time, retesting in the 
same apparatus was performed 7 and 10 days post-occlusion. 
5.3 Results 
Locomotor hyperactivity was observed in all groups following 
ischemia/sham-surgery. In sham-operated animals the period of hyperactivity 
was very brief (Figure 5-1) and was observed immediately after the animals 
regained consciousness. A greater degree of acute behavioural activation was 
observed following ischemia (Figure 5-1). However, the pattern following 3 and 5 
minutes of ischemia was biphasic, with an initial period of decreased locomotor 
activity before the period of hyperactivity began. Animals in the 3 and 5 minute 
ischemic groups usually righted themselves within 15- 30 minutes post-
occlusion, after which they assumed a hunched posture. The majority of animals 
remained inactive for approximately 2 - 3 hours. The duration of "ischemic 
hunch" was greater after 5 minutes than 3 minutes of ischemia and was not 
observed in animals who received a 1.5 minute occlusion (Figure 5-1). Once the 
"ischemic hunch" phase ended, all ischemic animals exhibited a period of 
increased locomotor activity that was significantly above the levels measured 
from sham-operated animals (Table 5-1). The duration of this heightened 
locomotor activity was related to the severity of ischemia, lasting 3 - 4 hours after 
a 1.5 minute occlusion and longer than 24 hours after a 5 minute occlusion. Brain 
temperature was also significantly elevated in the 3.0 and 5.0 minute occluded 
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groups (Table 5-2). However, brain temperature returned to control levels much 
more quickly than activity in these groups. Brain temperature is usually 
positively correlated with activity. However, as shown in the 5.0 minute group in 
Figure 5-1, this relationship does not always exist. Increased locomotor activity 
in animals subjected to 5 minutes of ischemia continued beyond 24 hours, in 
animals where postischemic recordings have been made for 3 days it has been 
observed that activity levels do not return to control values until-- 42- 48 hours 
post-occlusion. 
The acute behavioural pattern consisted of repetitive circling of the cage 
with frequent rearings in the comers in a stereotyped fashion. While an animal 
was in this phase of behavioural activation many species typical activities, such 
as paper shredding, grooming, eating and drinking were either not performed, or 
were briefly attempted and then abandoned. This was especially true during the 
early stages of increased locomotor activity and gradually became less apparent. 
Ischemic durations of 1.5 minutes caused very brief alterations in typical gerbil 
behaviour. For example, an animal occluded for 1.5 minutes would normally 
resume paper shredding within 6 hours postischemia, whereas an animal 
occluded for 5 minutes would not resume paper shredding activity until-- 30- 48 
hours postischemia. It was also observed that ischemic animals seemed to be 
hyper-reactive during the phase of behavioural activation. Certain acoustic 
stimuli (e.g. a high pitched tone) triggered a dramatic increase in locomotor 
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activity above that already being exhibited (Figure 5-2), whereas the response of 
sham animals to the same sound was almost undetectable. 
Both intraischemic hypothermia and hyperthermia altered the acute 
postischemic behavioural profile (Figure 5-3). Lowering brain temperature during 
ischemia resulted in the peak behavioural activation occurring earlier in the 
postischemic period (see also Figure 3-2) and the behavioural activation 
attenuated more quickly. Intraischemic hyperthermia results in a greater duration 
of "ischemic hunch". However, temperature and activity were not monitored for 
long enough to precisely determine the length of acute postischemic 
hyperactivity in this group. It may have persisted for a longer interval than the 
5. 0 minute normothermic group, which display locomotor hyperactivity until ,...., 48 
hours post-occlusion. The heightened locomotor activity of the hyperthermic 
group during the first minute of the open field session (,...., 72 hours postischemia) 
suggests that these animals may still be generally hyperactive at this time. 
The first exposure to the open field apparatus was 3 days postischemia. 
All ischemic groups and shams started with similar levels of activity on test day 
3, minute 1 (except the hyperthermic group, see results of intraischemic 
temperature manipulations). Sham-operated animals and the 1.5 minute occluded 
animal tended to habituate after the 2nd minute, showing decreased levels of 
activity with time. The groups occluded for 3 or 5 minutes exhibited what 
appeared to be a sensitization response, i.e., an increase in locomotor activity 
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which was most pronounced in the 5 minute occluded group (see total session 
scores in Figure 5-4 and activity scores per minute in Figure 5-5). 
In addition to the activity measures, there were other subtle differences in 
behaviour. The motoric responses of animals subjected to ischemia for 3 or 5 
minutes were less fluid than control animals, appearing slightly jerky. Normally, 
these differences in movement were subtle, however, in a few cases changes in 
movement following ischemia were more pronounced. In these extreme cases the 
animal's locomotor movements were obviously jerky, resembling the movements 
of a frog and always coincided with lower open field scores. Interestingly, 
movement disturbances have not been noted in ischemic animals when they are 
observed in their home cages immediately preceding exposure to the open field. 
Following the open field session, animals remained hyperexcitable for a short 
time (,..., 5 minutes) before settling down. Post open field hyperexcitability 
appeared to be greater in 3 and 5 minute ischemic animals than in control animals, 
but this was not systematically studied. 
' 
The percentage of locomotion around the perimeter versus centre 
crossings was not systematically assessed. However, it was observed that 3 and 
5 minute occluded animals exhibit a prominent pattern of continual forward 
locomotion around the perimeter, with very little or no interruption to engage in 
other behaviours, · at least on their first exposure to the open field environment. 
In contrast, sham controls cross the centre of the maze as well as locomoting 
around the sides and frequently stop to rear or sniff. 
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As with the acute behavioural changes, temperature also influenced the 
chronic behavioural alterations following ischemia. Hyperthermia increased the 
degree of behavioural activation and hypothermia decreased the level of open 
field activity. In some cases, intraischemic hypothermia was so protective that 
the open field responses were identical to the sham -operated animals, in both the 
within session pattern and the absolute level of activity, which has already been 
discussed in Chapter 3 (see Figure 3-4B and 3-5B). Animals whose brain 
temperature was raised to 38 oc during ischemia were interesting in that they 
were the only group whose frrst minute open field scores on day 3 were not 
I 
between 60- 80 squares. On day 3, the hyperthermic group crossed an average 
of 130 squares during the first minute of the test session, minutes 2 and 3 were 
slightly lower, then a sensitization-like pattern was observed (Figure 5-6). 
Whereas the responses in the hypothermic group approached the sham-operated 
animals with time, the hyperthermic group remained higher than all other groups 
on all test days. 
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Figure 5-1. Post-surgery brain temperature and activity measurements 
Mean brain temperature is plotted as a line with the reference on the left axis. 
Mean activity measurements are illustrated by the black bars with the standard 
deviation of the group indicated by the shaded area, the reference for activity 
levels is shown on the right axis. All data in the ischemic groups begin at the end 
of occlusion. Data for the sham-operated group is shown at a similar time with 
respect to length of surgery. The 1.5 minute occlusion data are based on n = 4 for 
the first 18 hours and n = 1 for 18- 24 hours. 
See Tables 5-1 and 5-2 for summary data and statistical comparisons. 
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Table 5-1. Postischemic activity 
Mean activity level averaged in 3 hour increments, from end of occlusion to 24 
hours post-occlusion. Variance has been excluded from the table for clarity. The 
standard deviations for each group are plotted on the graphs in Figure 5-1 . All 
post-hoc comparisons in the ischemic groups are to the sham-operated group 
I 
* ** (Dunnett t), p < 0.05, p < 0.01. 
Time 0-3 3-6 6-9 9-12 12-15 15- 18 18-21 21-24 
Post-Surgery hours hours hours hours hours hours hours hours 
Sham- 1.2 0.4 0.6 0.4 0.35 0.3 0.4 0.46 
Operated 
1.5 minute 3.9 ** 0.8 0.6 0.3 0.35 0.3 1.3 0.24 
3.0minute 2'.6 * 6.3 ** 4.1 * 2.3 * 1.4 1.0 1.1 1.0 
5.0minute 0.4 4.2 4.9 ** 4.3 ** 4.3 ** 3.8 ** 4.1 ** 2.7* 
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Table 5-2. Postischemic tetnperature 
Mean brain temperature for the sham-operated, 1.5, 3 and 5 minute occluded 
groups averaged in 3 hour increments, from end of occlusion to 24 hours post-
occlusion. Group variance is the standard deviation. All post-hoc comparisons 
in the ischemic groups are to the sham-operated group (Dunnett t), * p < 0.05, **p 
<0.01. 
0-3 3-6 6-9 9-12 12-15 15-18 18-21 21-24 
hours hours hours hours hours hours hours hours 
Sham 37.1±.5 37.1±.6 37.1±.5 36.9±.5 36.7±.3 36.5±.3 36.4±.2 36.6±.2 
1.5 37.3±.2 36.7±.4 36.6±.2 36.2±.3 36.3±.4 36.2±.4 36.3±1.1 35.6 
3.0 ** * 37.4±.4 37.9±.4 37.8±.5 36.9±.4 36.5±.4 36.5±.4 36.5±.5 36.5±.4 
5.0 37.2±.3 * 37.5±.2 37.8±.4 36.9±.3 36.6±.4 36.4±.5 36.4±.6 36.6±.5 
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Figure 5-2. Increase in locomotor activity triggered by external noise 
Brain temperature and activity in an ischemic animal during the early phase of 
behavioural activation. The occlusion duration was 3 minutes. Note the large 
increase in activity, lasting 5 minutes, which was triggered""' 180 minutes after 
occlusion. The scale on the right y-axis is 5 times greater than in the activity plots 
in Figure 5-1. Other ischemic animals have shown occasional activity spikes 
outside the normal ischemic range, but not to the extent of the animal shown 
here. Usually unfamiliar sounds can trigger brief increases in activity in ischemic 
animals, ranging between 20 and 30 counts per minute. 
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Figure 5-3. Intraischemic hypothermia, normothermia and hyperthermia- effects 
on postischemic temperature and activity 
Post-surgery brain temperature and activity measurements in animals operated 
under brain temperature conditions of: A, intraischemic hypothermia (n = 1); B, 
intraischemic normothermia (n = 1); C, intraischemic hyperthermia (n = 3). Note 
that temperature and activity recording in the hyperthermic group (C) was 
discontinued at 9.5 hours postischemia (note the duration of the temperature plot 
on the graph in C). 
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Figure 5-4. Total open field activity scores on days 3, 7 and 10. Sham-operated 
animals and animals occluded for 1.5, 3.0 and 5.0 minutes. 
Sum of the number of squares crossed during each minute of the 10 minute 
sessions. Sham-operated animals (shaded bars), 1.5 minute occlusion (open bars), 
3.0 minute occlusion (filled bars), 5.0 minute occlusion (hatched bars). Error bars 
indicate the standard deviation, post hoc comparisons of the ischemic groups to 
the sham-operated group were made using the Dunnett t, * p < 0.05 ** p < 0.01. 
In the following figure, Figure 5-5, the activity pattern during each session is 
plotted for each of the four treatment groups. 
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Figure 5-5. Open field line graphs, days 3, 7 and 10. Sham-operated animals and 
animals occluded for 1.5, 3.0 and 5.0 minutes 
Each point represents the mean number of squares crossed per minute. Open field 
sessions were 10 minutes in length. Sham-operated animals (open circles), 1.5 
minute occlusion (filled circles), 3.0 minute occlusion (filled triangles), 5.0 minute 
occlusion (filled squares). The data in the 1.5 minute occluded group is only 
based on 1 animal, the 3 other animals shown in the temperature/activity plot 
(Figure 5-1) were not tested in the open field. Other data collected in our lab 
using this occlusion duration have found similar results, i.e., no evidence of an 
increased locomotor response in the open field (Corbett, Crooks, Dooley and 
Evans, unpublished data). 
Note the similarity in the responses of all groups during the first minute on 
test day 3, the initial exposure to the novel environment. Summary data of the 
total scores on each test day is presented in Figure 5-4, along with the standard 
deviation of each group. Error bars were not included in this graph in order to 
clearly show the group means and patterns of behaviour. 
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Figure 5-6. Open field line graphs, days 3, 7 and 10. Sham-operated animals and 
5 minute occluded animals (hypothermic, normothermic and hyperthermic) 
Open field activity on days 3, 7 and 10 post-surgery. Five minute occlusion, 
hyperthermia (squares- top left side filled), 5 minute occlusion, normothermia 
(filled squares), 5 minute occlusion, hypothermia (squares- bottom right side filled) 
and sham operated animals (open circles). Error bars were not included in this 
graph in order to clearly show the group means and patterns of behaviour. Note 
that the y-axis on this graph ranges from 0 to 150, whereas the y-axis in Figure 5-
5 only ranged from 0 to 125. 
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Figure 5-7. Unpublished data from Corbett, Hewitt, Wong and Nurse (1989), see 
discussion. Comparison of open field behaviour following a 5 minute ischemic 
episode when testing is started either 24 hours post-occlusion versus 7 days post-
occlusion. Group A, 5 minute occlusion with daily testing beginning 24 hours 
post-surgery, open squares (n = 5). Group B, 5 minute occlusion with daily 
testing beginning at 7 days post-surgery, open circles (n = 5). Sham-operated 
animals, with testing beginning 24 hours post-surgery, open triangles (n = 8). 
Error bars have not been added in order to more clearly show the group means. 
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5.4 Discussion 
Ischemia induces both an acute and a chronic increase in locomotor 
activity. The exact cause of both behavioural alterations is unknown, but the 
magnitude of the behavioural change is related to the severity of the ischemic 
insult. Due to the vulnerability ofthe CAl area of the hippocampus to ischemia 
it has been proposed by tnany investigators that this region is responsible for 
the changes in behaviour. Abnormal activity in the CAl cells may cause the 
acute behavioural effect (K.uroiwa et al., 199la), loss of cellular function or CAl 
cell death may be responsible for the deficits observed in the open field (Gerhardt 
and Boast, 1988; Wang and Corbett, 1990; Mileson and Schwartz, 1991; Babcock 
et al., 1993). 
The pattern of acute postischemic behavioural activation is intriguing in 
that the animal's behaviou.:rr provided an index as to the severity of the ischemia. 
Ischemic durations of 1.5, 3 and 5 minutes produce clearly different behavioural 
profiles. The sham operated animals displayed a brief period of increased 
locomotor activity immediately following surgery, but this quickly recovered (i.e. 
average activity counts < 1 ). This post-anaesthesia activity elevation is 
commonly observed in gerbils. In the ischemic animals however, a different 
behavioural response was observed and both the latency to reach peak activity 
as well as the duration of locomotor activation varied depending on the length 
of the ischemic episode. S:mall differences in the ischemic duration (i.e. 1.5 
133 
versus 3 versus 5 minutes) had very marked differences on postischemic 
behaviour. 
During the early postischemic period, the 3 and 5 minute ischemic groups 
initially displayed "ischemic hunch" before the phase of increased locomotor 
activity began. During this time the animals were conscious, but generally 
remained inactive. The period of ischemic hunch may reflect the length of time it 
takes for the brain to recover a relatively "normal" level of functioning. Ischemia 
I 
causes a disturbance in ionic balance, a massive release of neurotransmitters, 
loss of energy reserves, hypoperfusion and depression of protein synthesis. 
The ischemic hunch phase may indicate the length of time it takes for the brain to 
recover from these perturbations. In magnetic resonance imaging studies, it has 
been found that recovery of high energy phosphates occurs within minutes 
following ischemia (Nowak et al., 1985; Haraldseth et al., 1992), so presumably 
A TP recovery would not explain the lengthy period of ischemic hunch. 
However, normalization of other functions, such as protein synthesis, can take 
several hours. In· addition, the rate of recovery of protein synthesis varies with 
the length of ischemia and differences in intraischemic temperature. Foil owing 
I 
brief durations of ischemia (i.e. 2 minutes) the recovery of protein synthesis in 
the forebrain is much faster than following a 5 minute ischemic episode 
(Nakagomi et al. 1993). Interestingly, the prolonged suppression of protein 
synthesis during the postischemic period is reversed more quickly when 
intraischemic hypothermia is induced (Widmann et al., 1993). 
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Once behavioural activation began, the maximum level of activity was 
similar in all groups (a maximum of approximately 7 counts). This peak was 
observed in both the sham operated and the 1.5 minute occluded animals within 
the first hour following surgery, but the 1.5 minute group continued to display 
this high level of locomotor activity for a few hours. The 3 and 5 minute ischemic 
groups reached the peak at 3 and 5 hours, respectively. While the 3 minute 
group only spent approximately 2 hours at this high level of activity and then 
showed a gradual decline, the 5 minute group maintained this high activity level 
for almost 24 hours. 
The cause of the acute increase in activity is unknown, but it has been 
speculated that abnormal activity in the CAl area of the hippocampus is 
I 
responsible (Kuroiwa et al., 199la). Rossman's group measured locomotor 
changes after a 5 minute ischemic episode in gerbils, then 1 week later induced a 
second ischemic episode. The first 5 minute period of ischemia produced a 
dramatic increase in activity which lasted approximately 1 day (the greatest 
behavioural activation occurred during the first 12 hours) and ultimately 83% of 
CAl cells were lost. If a second 5 minute ischemic episode was induced 1 week 
later, there was only a brief increase in activity, which quickly subsided within 3 -
4 hours. Since the majority of CA 1 cells would have died by 1 week postischemia 
the authors concluded that the presence of the CAl neurons was necessary to 
cause postischemic hyperactivity. However, these data are open to other 
interpretations. First of all, many other brain regions, in addition to the CA 1 
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region, are affected by an episode of forebrain ischemia, including the striatum, 
neocortex, septum, subiculum, CA2, CA3a and CA4 regions (Kirino, 1982; Crain 
et al., 1988; Akai and Yanagihara, 1993). Thus, a brain structure other than CAl 
may be responsible for the behavioural changes. Alternatively, tolerance could 
develop to repeated ischemic episodes (Kitagawa et al., 1990) such that the 
magnitude of the behavioural response lessens after the second ischemic 
episode, irrespective of the loss of the CA 1 neurons. 
If CA 1 neurons are responsible for the acute changes in activity following 
ischemia, this could result from stimulation of subicular neurons, which in turn 
have a prominent projection to the nucleus accumbens (Swanson and Cowan, 
1977; Kelley and Domesick, 1982), a structure known to be involved in control of 
locomotor activity (Mogenson and Nielsen, 1984). Yang and Mogenson (1987) 
demonstrated that stimulation of subicular cells with NMDA results in motoric 
activation, which is blocked by concurrent application of a dopamine D2 
antagonist into the nucleus accumbens. In the postischemic period, increased 
I 
trring of CAl neurons could activate the accumbens-mesencephalic locomotor 
system resulting in an increase in activity. A transient elevation in CA 1 cell 
discharge could be responsible for the short period of behavioural activation 
seen after 1.5 minutes of ischemia (Nowak et al., 1985). The longer (3 and 5 
minutes) durations of ischemia which induce delayed necrosis in CAl, could lead 
to an enhanced behavioural activation prior to the eventual death of the CA 1 
cells. There have been some reports of hyperexcitability in the CA 1 region 
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postischemia (Suzuki et al., 1983). An earlier study (Brown et al., 1979) suggested 
that circling behaviour following carotid artery occlusion was due to epileptic 
activity. In a study by Mitani et al. (1989) using a gerbil model of global 
ischemia, carotid arteries were occluded for various durations (including 1.5, 3 
and 5 minutes) and spontaneous extracellular unit activity was recorded 
postischemically in anaesthetized animals for 60- 90 minutes. Interestingly, 
following a 1.5 minute occlusion there was a period ofhyperexcitability in CAl 
within the frrst hour. The spike discharges in this group were 4 times the 
frequency observed prior to ischemia. This period of high frequency discharges 
• 
corresponds to th~ phase of increased behavioural activation observed after 1.5 
minutes of ischemia (Figure 5-l). In this same study, Mitani and colleagues 
concluded that there was no hyperexcitability following 3 or 5 minutes of 
ischemia. However, as shown here, the phase of behavioural activation 
following occlusions of either 3 or 5 minute duration does not begin until a few 
hours after ischemia. Thus, it is possible that there were high frequency 
discharges in these groups but they might have been missed by terminating the 
recording session within 60 - 90 minutes of ischemia. There has been 
considerable debate over the issue of postischemic hyperexcitability. Many 
labora~ories, even using periods of extended recording (Buzsaki et al., 1989), have 
been unable to replicate the original fmdings of Suzuki and colleagues (1983). 
These conflicting results could be due to species differences and/or differences 
in ischemic models. Gerbils were used in both the Suzuki and Mitani studies, 
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however, Buzsaki used the rat 4VO model. In our laboratory, it has been 
observed that rats (2VO model) do not exhibit the same level of postischemic 
behavioural activation as gerbils (Corbett and McKay, unpublished results). 
This might reflect a greater tendency for hyperexcitability in gerbils than in rats. 
However, rats do show an increased behavioural activation 24 - 72 hours 
postischemia. Correspondingly, Chang et al. (1989) have reported that there is 
increased frring of CAl neurons on day 2 and day 3 after 2VO in rats, although 
not on day 1. Unfortunately, there have only been anecdotal reports linking 
increased behavioural activation to EEG changes in the CAl region (Armstrong 
et al., 1989). Studies combining in vivo recording with detailed behavioural 
monitoring in freely moving animals, would help determine the extent to which 
neuronal activity in CA 1 is involved in the behavioural activation observed after 
an isc~emic episode. 
There are many other explanations that could account for the increased 
activity in the early postischemic period. Cytokines, such as interleukin 1, are 
pyrogenic and cause behavioural arousal possibly mediated by the central 
actions of corticotrophin-releasing factor (CRF) (Berkenbosch et al., 1987, 
Sapolsky et al., 1987; Rothwell, 1989 and 1990). Concentrations ofinterleukins 
and CRF are known to increase in brain tissue after ischemia (Minami et al., 1992; 
Rothwell and Relton, 1993; Strijbos et al., 1994). Transmitters such as dopamine 
and glutamate have well-known effects on behavioural activation (Malec and 
Kleinrok, 1972; Pijnenburg et al., 1976; Donzanti and Uretsky, 1983). During 
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ischemia there is a massive release of glutamate (glutamate levels rise ,.._, 8 times 
above normal) and dopamine (300 - 500 %increase above normal, Globus et al., 
1988a). While glutamate levels have been shown to return to control values 
soon after ischemia, a secondary rise in dopamine occurs during the early 
postischemic phase (Ahnet al., 1991). Unfortunately, long-term monitoring of 
transmitter levels, such as dopamine, during the postischemic period has not 
been c~ied out. This might be useful since the acute behavioural arousal 
induced by ischemia closely resembles the description of animals injected with 
psychomotor stimulants: 
"(Amphetamine) produces an increase in the incidence of forward 
locomotion, head movements, snif:fmg and rearing (i.e. the animal 
becomes generally hyperactive) and a concomitant decrease in the 
incidence of other behaviours, such as grooming ... It should be 
noted that the pattern of locomotion produced by amphetamine is 
not normal in all respects, but is itself abnormally stereotyped", 
.(p.161 and 162, Robinson and Becker, 1986). 
Regardless of the mechanism for the acute behavioural change, it provides 
a useful measure of ischemic severity. Many models of cerebral ischemia, 
including the gerbil model used here, induce the ischemic episode under 
anaesthesia. This results in an inability to use behavioural signs (i.e. loss of 
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rightin~ reflex) in order to determine the effectiveness of the occlusion. Other 
ischemia models, such as the rat 4VO model, are often carried out in the absence 
of anaesthetics. If certain critical behavioural symptoms are not observed (i.e. 
loss of the righting reflex) then animals are often discarded from the experiment. 
Since a small percentage of gerbils may have a functional circle of Willis, thus 
resulting in some blood flow via the collateral circulation, postischemic 
behavioural alterations could be used as a marker of effective or ineffective 
ischemia. In addition, many pharmacological studies now study the effects of 
delayed treatment (i.e. 12- 24 hours postischemia). Therefore, the period of 
postischemic recovery prior to drug administration could be used to compare the 
behav~oural responses among animals to ensure that different treatment groups 
had consistent ischemic injury before initiation of treatment. However, once 
drug treatments are administered, activity pattems can become confounded by 
side effects of the drugs, such as sedation. Indeed, many of the pharmacological 
agents that have been tested in animals models of ischemia (i.e. MK-801, NBQX, 
and the synthetic omega-conopeptide SNX-111) have sedating properties in the 
dose ranges that are protective. 
Depending on the duration of the occlusion, within 1 - 2 days the 
behavioural activation declines and activity levels return to control values. In 
addition to the retum to normal activity levels, species typical behaviours, such 
as grooming and paper shredding are also exhibited. A few days after the 
ischemic episode it would be difficult, if not impossible, to distinguish ischemic 
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from sham-operated animals by observing them in their home cages. However, if 
animals are placed in a novel environment, such as an open field apparatus, 
ischemic animals are readily distinguished from shams. The increased locomotor 
activity observed ·in an open field following occlusion durations of 3 and 5 
minut~s has been previously reported by many groups (Chandler et al, 1985a; 
Chandler et al., 1985b; Gerhardt and Boast, 1988; Babcock et al., 1993,, Mileson 
and Schwartz, 1991). A study by Wang and Corbett (1990), demonstrated that 
novelty is a requirement for this ischemia-induced change in behaviour. If 
animals were pre-exposed to the open field environment before the ischemic 
episode then the usual pattern of enhanced locomotor activity was not seen 
when the animals were re-exposed to the open field after ischemia. Thus, general 
locomotor hyperactivity is not the explanation for the enhanced behavioural 
activation in the open field since both ischemic groups, pre-exposed and naive, 
should have shown similar activity levels . 
. An accepted explanation that has been put forward for the behavioural 
response of ischemic animals to the open field test is that the loss of CA 1 
neurons alters processing of information through the tri-synaptic circuit of the 
hippocampus. This alteration in hippocampal processing may then lead to 
memory deficits, especially for spatial information, such that ischemic animals 
who have sustained damage to the CA 1 sector do not habituate to novel 
environments as quickly as normal animals (Wang and Corbett, 1990; Babcock et 
al., 1993). If the animals are pre-exposed to the open field before ischemia, there 
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is no deficit because the animals have already habituated to the environment and 
stored this information elsewhere. The hippocampus is not believed to be a site 
for long-term me~ory storage (Scoville and Milner, 1957; Zola-Morgan et al., 
1986). This interpretation of the open field deficit is consistent with lmdings 
from humans with hippocampal injury. For example, patient R.B. who had 
ischemic injury restricted to the CA 1 field of the hippocampus as a result of 
cardiac arrest, suffered from anterograde amnesia deficits while "older" memories 
were left intact. The open field deficit has been repeatedly demonstrated in 
ischemic animals and has proved to be invaluable as an index of hippocampal 
injury since open field behaviour correlates highly with CAl cell loss (Gerhardt 
and Boast, 1988; Mileson and Schwartz, 1991; Nurse and Corbett 1994) and not 
with damage to the caudate or cortex (Mileson and Schwartz, 1991). The open 
field test is also useful as a functional measure since deficits can be 
demonstrated for months after the ischemic event. In a long-term survival study, 
ischemic animals were tested in an open field 5, 10, 30 and 180 days postischemia 
(Colbourne and Corbett, 1994b; Colbourne and Corbett, 1995). Locomotor 
activity was significantly higher in the ischemic group than the sham-operated 
group on all test days. These data were interpreted as demonstrating a 
persistent memory deficit (lasting up to 6 months) in ischemic animals. However, 
given the simplicity of the open field test it is somewhat surprising that the 
animals have such difficulty habituating to this environment. Indeed, other 
studies have shown that ischemic animals have no detectable deficits in more 
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conventional tests of spatial memory, such as the Morris milk maze, if testing 
starts 21 days postischemia (Corbett et al., 1992) . 
. Other results from an unpublished experiment by Corbett, Hewitt, Wong 
and Nurse ( 1989) raise questions about the exact nature of the open field deficit. 
In this unpublished study, two ischemic groups were compared to a group of 
sham-operated animals. Each ischemic group received 5 minute carotid artery 
occlusions. All groups were exposed to the open field daily, post-surgery, for 7 
test days. The only difference between the two ischemic groups was the timing 
of the frrst exposure to the open field. In Group A open field testing was initiated 
24 hours after ischemia, in Group B testing was delayed and the first exposure to 
the open field was 7 days postischemia. The sham-operated animals were tested 
starting 24 hours post-surgery. In Group A, the typical ischemic deficit was 
observed, which gradually recovered with daily testing. However, in Group B, 
both the absolute activity scores and the pattern of the response during each 
session were virtually identical to the sham-operated group. There were no 
detectable differences between Group B and the sham operated animals (see 
Figure 5-7), but the two 5 minute ischemic groups (Groups A and B) had 
significantly different behavioural profiles even though both groups had similar 
(moderate to severe) CA 1 cell loss. What does this study suggest? Perhaps the 
open field deficit we routinely observe following ischemic durations of 3 minutes 
or longer is the result of sensitization triggered by novelty. If so, there may be a 
critical period following ischemia in which sensitization can take place. If the 
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animals are exposed to the open field after the critical period then they behave 
normally. In contrast, animals sensitized to the open field during the critical 
period may experience context-dependent conditioning so that subsequent 
intermittent exposures to the same environment (i.e. at 10 days or even 6 months 
post-occlusion) can trigger an increase in locomotor activity. 
Context-dependent conditioning of locomotor activity can be induced 
pharmacologically, mainly by amphetamine-like stimulants and J..L-opiates 
(Robinson and Becker, 1986) and also by stress (Antelman et al., 1980). 
Behavioural changes resulting from sensitization have been reported to last for 
months (Babbini et al., 1975; Kalivas and Stewart, 1991). Ifthe postischemic 
deficit is a result of context-dependent conditioning it suggests that the problem 
is not an inability to learn or remember the environment, but instead a very 
strong conditioning response due to sensitization on the trrst exposure. 
Sensitization could be due to a generalization from the acute behavioural 
activation caused by ischemia to other stressors such as novelty, or it could be 
related specifically to CA 1 neuronal loss. 
·Hippocampal lesions produced by methods other than ischemia have long 
been known to cause changes in locomotor activity (Kimble, 1963; Teitelbaum 
and Milner, 1963; Douglas and Isaacson, 1964; Jarrad, 1968). Increases in 
locomotor activation have been observed in both the animal's home cage and in 
novel environments, such as the open field test. As with ischemia, the exact 
cause of these behavioural changes is unknown. Glickman et al. (1970) have 
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shown· that home cage locomotor activity is increased after hippocampectomy in 
gerbils, with assessments starting 17 days post-surgery. If these locomotor 
changes are due to the same mechanisms as the ischemia-induced behavioural 
alterations, then is the time course for acute home cage changes related to the 
magnitude of the hippocampal destruction? Following ischemia the hippocampal 
damage is much less extensive than in many studies of hippocampal lesions, with 
ischemia-induced necrosis contmed primarily to the dorsal CAl sector and the 
period of home cage activity changes is substantially shorter. As shown here, 
increasing durations of ischemia (i.e. 5 minutes versus 3 minutes) which increase 
hippocampal damage, lead to longer durations of elevated activity in familiar 
environments. Inducing ischemia (5 minutes duration) under slightly 
hyperthermic conditions, may have led to acute behavioural changes that 
persisted for at least 72 hours (rather than 48 hours) since the open field scores 
on test day 1, minute 1, were extremely high in this group. Hyperthermia also 
increased the extent of hippocampal damage, such that necrosis extended into 
the CA3 sector, which normally appears quite healthy after 5 minutes of ischemia 
at normothermia. If increasing degrees of hippocampal injury lead to longer 
periods of heightened locomotor activity in familiar environments, this may affect 
the time period in which deficits will be elicited in novel environments such as an 
open field. Babcock et al. ( 1993) induced 5 minute occlusions in gerbils, with 
temperature maintenance (3 8 °C), followed by open field testing at various times 
in the postischemic recovery period. In some groups testing was delayed until 
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13 days post-occlusion. In contrast to what we found in the unpublished 1989 
study, Babcock et al. (1993) reported that the open field deficit was still apparent 
when initial testing began 13 days post-occlusion. There was no quantification 
of ischemic damage in this study, however, the representative photograph of the 
hippocampus from an ischemic animal appeared to have some injmy in the CA3 
sector as well as in the CA 1 region. This degree of hippocampal injmy is greater 
than the level of damage we obtained in our 1989 study and might have lead to a 
longer duration (i.e. 2 weeks versus less than 1 week) during which open field 
deficits would be elicited in novel environments. 
Understanding the nature of a behavioural deficit following brain injury is 
a difficult undertaking. When the brain has been lesioned, researchers are not 
really studying the isolated function of the damaged region, but more 
specifically, how the remainder of the brain functions in the absence of this 
structure. In animal models, the task is further complicated by the inability to use 
many of the same tests that are used with humans since these often involve 
I 
language. In addition, the testing protocol can have a large effect on the 
conclusions drawn from behavioural experiments. If locomotor activity had only 
been tested in familiar environments then it would have been concluded that the 
locomotor activity normalized within several hours to two days, depending on 
the duration of occlusion. This would have added to the conflicting reports in 
the literature, where groups comparing similar occlusion durations have reported 
vastly different time courses of behavioural activation (Gerhardt and Boast , 
1988; Kuroiwa et al., 1991a,b; Colbourne and Corbett, 1995). Both acute and 
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chronic deficits may be related to CA 1 cell loss, but each of these behavioural 
changes will have to be studied in more detail in order to determine the 
mechanism(s) underlying the locomotor activation. The changes in the early 
postischemic period may help to explain some of the neuronal events that 
underlie delayed neuronal death. Understanding the basis of these behavioural 
disturbances may lead to the development of new pharmacological therapies for 
ischemia. The open field test reveals that there are deficits which persist in 
ischemic animals after CA 1 neurons have died, which is consistent with reports 
of long-lasting impairments in human patients (Zola-Morgan et al., 1986). It 
remains to be established whether the open field deficits that have persisted for 
months after the ischemic episode in animals are due to a persisting memory 
impairment, or whether this reflects a carry-over effect from earlier test sessions. 
Whatever the case, it has been shown in several experiments (see Chapter 3) that 
the magnitude of increased locomotor activity in the open field test (measured 
during the first week postischemia) corresponds to the size of the field responses 
recorded from the CAl region and both functional measures relate to the 
magnitude of CA 1 cell loss. Thus, the open field remains the best behavioural 
test to date for functionally assessing the magnitude of global ischemic injury. 
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CHAPTER 6: DISCUSSION 
6.1 Summary of Major Findings 
In Chapters 3 and 4, two different putative interventions to prevent 
ischemic injmy, intraischemic hypothermia and NBQX, were found to provide 
protection against cell injmy resulting from global ischemia. Although NBQX is 
a glutamate receptor antagonist, the protection it provided was through lowering 
brain temperature. Intraischemic hypothermia is a remarkably effective treatment. 
Even 3 weeks following the ischemic insult, both the functional measures and the 
CA 1 cell ratings were indistinguishable from controls. This demonstrates that 
appropriate treatments can preserve function and prevent cell death. In the 
absence of temperature regulation, NBQX provided histological preservation 4 
days postischemia. However, functional outcome based on electrophysiological 
recordings from the CA 1 region, was not robust. 
lntraischemic hypothermia preserved both behavioural and 
electrophysiological function. In previous studies of intraischemic hypothermia, 
behavioural tests done weeks after the ischemic insult have shown thatfunction 
is preserved (Green et al., 1992). However, as discussed in Chapter 3, it may be 
more important to carry out behavioural tests soon after the ischemic episode, 
before any substantial recovery of function has taken place, since this may 
obscure an underlying deficit. For example, within the intraischemic hypothermia 
group CAl cell ratings were lower in some animals than a sub-group of 
hypot4ermic animals with total or near total protection. It is unlikely that these 
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behavioural deficits in the IBH-high sub-group would have been detected with 
later testing. Even in untreated animals:J the open field deficit following ischemia 
diminishes with increasing recovery time:J especially if early testing has not been 
carried out (see Chapter 5). 
Electrophysiological recording complements the behavioural testing in 
that it can be carried out at later survival times and the cell region of interest (i.e. 
CAl) yan be recorded from directly. With behavioural tests one region cannot 
be tested in isolation and most often it is unclear which region(s) is contributing 
to a given behavioural deficit. In spite of these complications:J behavioural 
testing permits the overall cognitive functioning to be evaluated:J something not 
easily achieved with electrophysiology alone. 
The NBQX data (Chapter 4) are quite important since they strongly 
suggest that direct blockade of AMP A receptors located on CA 1 cell bodies is 
not responsible for the neuroprotection observed. Two lines of evidence help 
support this claim: (i) no protection was found when hypothermia was prevented 
after administration ofNBQX and (ii) a precise simulation of the NBQX-induced 
temperature profile in the absence of the drug was neuroprotective. Of course:J 
the fact that the degree of protection declined at a faster rate in the simulated 
temperature group than it did in the NBQX group raises the possibility that the 
drug offers an additional protective effect independent of a reduction in 
temperature. Thus:J even if the simulated hypothermia had been maintained for 
the same duration as NBQX-induced hypothermia (i.e.--- 100 hours) the 
protection may have still been inferior to that achieved with NBQX. However:J 
the improved efficacy found with deliberate hypothermia (32 °C) when the 
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duration of treatment is lengthened from 12- 24 hours (Colbourne and Corbett, 
1994a) supports the hypothesis that the protection obtained with NBQX is due 
to a significantly greater duration of hypothermia. If so, keeping the temperature 
at a subnormal level for 4 - 5 days should achieve a comparable degree of 
protection to that observed with NBQX. 
Regardless of the mechanism of action of NBQX, neuronal functioning 
(assessed electrophysiologically) is reduced at four days postischemia, a time 
when cell counts are indistinguishable from control animals. Therefore, NBQX 
does not provide the robust functional protection of intraischemic hypothermia, 
presumably because the degree of hypothermia achieved with NBQX is so mild, 
i.e., a decrease of only 1. 0 - 1.5 °C. Indeed, increasing the level of hypothermia 
leads to increased neuronal and functional protection. For example 32 oc is far 
more effective than 34 oc (Colbourne and Corbett, 1995). 
The changes in locomotor activity following ischemia were described in 
Chapter 5. Acute alterations in postischemic activity are a sensitive indicator of 
ischemia, even in cases of minimal injwy. For example, animals exposed to 
intraischemic hypothermia displayed a brief burst in locomotor activity about 2 
hours later, which quickly declined. Even in the IBH-low sub-group, which had 
virtually no injury in CAl and normal open field behaviour, there was still an 
acute increase in activity which was not different from the IBH -high group (data 
not shown). Increased locomotor activity is also apparent in the 1.5 minute 
occlud~d group in which there is no necrosis in the CA 1 region. Interestingly, 
the early activity patterns following 5 minutes of ischemia with intraischemic 
hypothermia did differ from the pattern following 1.5 minutes of ischemia at 
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normothermia, even though both groups had minimal CAl injmy. The 1.5 minute 
group did not exhibit ischemic hunch and the increase in activity peaked during 
the first hour. The intraischemic hypothermic group exhibited ischemic hunch 
and the peak behavioural activation occurred later. This suggests 5 minutes of 
ischemia with intraischemic hypothermia results in an insult that is greater in 
magnitude than an insult of 1.5 minutes duration at normothermia, but the 
reduced temperature enables recovery to take place. Moreover, the magnitude of 
the acute increase in locomotor activity is greatly enhanced with increasing 
occlusion durations. The difference between the 3 and 5 minute occlusion 
durations is quite striking, especially since the 3 minute duration is severe 
enough to kill> 80% of dorsal CAl neurons. 
Changes in open field behaviour measured after ischemia are thought to 
result from impairments in spatial memory (Wang and Corbett, 1990; Babcock et 
al., 1993). However, this interpretation does not explain why animals with early 
exposure to the open field, i.e., 1 to 3 days postischemia, exhibit higher levels of 
activitY on later test days than animals not previously exposed. It is possible 
that this effect is due to context-dependent sensitization and thus, dopamine 
antagonists, which block pharmacologically-induced sensitization (Stewart and 
Vezina, 1989), might block ischemia-induced sensitization. Such experiments are 
necessary if the ischemia-induced changes in the open field (and perhaps other 
behaviours) are to be understood. 
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6.2 Intraischemic versus Postischemic Treatments 
As discussed in the previous section, 6.1, earlier reports suggesting that 
intraischemic hypothermia provides long-term benefit have been confirmed by 
the study presented in Chapter 3. The protection obtained with postischemic 
administration of·NBQX, however, is questionable based on the results from the 
present studies, at best the protection provided is only partial. In view of these 
data it is unclear whether any purportedly protective pharmacological treatments 
administered during the postischemic period would achieve permanent 
neuroprotection . . 
The effectiveness of postischemic versus intraischemic treatments is 
dependent on the mechanisms involved in cell death and the mechanism of 
action of the protective treatment. In general, the events culminating in death of 
vulnerable neurons follow a three-step process: 
Ischemia -----~Reperfusion -----~Cell Death 
During the initial days following reperfusion, the repercussions of ischemia (and 
possibly postischemic events as well) become manifest and selective neuronal 
death results . Events occurring during the postischemic reperfusion period do 
have ah impact on the time course of cell death as was demonstrated with both 
the postischemic administration ofNBQX and the manual simulation of the 
NBQX temperatul-e profile. It remains to be established that any postischemic 
treatment will result in lasting neuroprotection. This issue is dependent on 
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whether cell death results from the ischemia itself, or whether events in the 
postischemic period also injure neurons. Two theoretical models are outlined: 
(i) Irreversible 
injury induced 
by ischemia 
(ii) Injury during 
the ischemic 
period 
) 
) 
) 
Maturation period for the 
injury to result in cell death 
Exacerbation ofinjmy 
during reperfusion 
Postischemic intervention 
prevents the exacerbation of 
IDJUty 
-----+> Cell death 
---+> Cell death 
---+) Reduction 
in cell death 
If scenario (i) is accurate then only intraischemic treatments will provide 
lasting protection~ An intervention during the postischemic period may alter the 
time course of events culminating in necrosis, possibly by weeks or months, but 
will not irrevocably halt the processes culminating in cell death. Scenario (ii) 
however is more optimistic, it assumes that neuronal death results from the 
combined effects .of ischemia and events during reperfusion. If this is the case, 
then a treatment which effectively reduces either the intraischemic or the 
postischemic process( es) will provide permanent neuroprotection. The strongest 
evidence in favour of the second scenario is the effectiveness of long duration 
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postischemic hypothermia (32 oc for 24 hours). This postischemic therapy 
provides an impressive degree of protection, but still the protection declines 
significantly between survival times of 1 month (,..., 90 % protection of CA 1 cells) 
and 6 months(,..., 70% protection of CAl cells) (Colbourne and Corbett, 1995), 
and might continue to decline beyond this time. Long-term survival studies (i.e. 
6 - 12 months) to assess the permanence of the neuronal protection obtained 
with intraischemic hypothermia will also need to be carried out in order to ensure 
that there is no significant decline. However, assessments made 2 months after 
intervention with intraischemic hypothermia (Green et al., 1992; Dietrich et al., 
1993) suggest that the degree of CAl cell preservation does not decrease with 
increasing survival times. 
6.3 Hypothermia: Possible Mechanisms of Action 
The mechanism(s) of action for the neuroprotective effects of hypothermia 
are unknown. It is possible that intraischemic and postischemic hypothermia do 
not necessarily work by the same mechanisms. Intraischemic hypothermia may 
lessen .the degree of injury that a neuron sustains during the ischemic period. 
However, when postischemic treatments are employed, the neuron may have 
already sustained a level of injury that is sufficient to cause substantial cell loss 
in untreated animals. Therefore, postischemic hypothermia must either reduce 
the impact of the injury sustained and/or reduce the events associated with 
reperfusion that may also contribute to cell injury. There are many ways in which 
hypothermia could act to protect against ischemic damage, and the unrivaled 
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protection achieved with hypothermia (both intra- and post-ischemic 
hypothermia), in comparison to all currently used pharmacological treatments, 
may be due to multiple protective actions. 
Hypothermia has been shown to stabilize neuronal membranes, thereby 
reducing leakiness and decreasing the magnitude of shifts in ionic balances, 
particularly Na+ and K+ (Astrup, 1982). Since maintenance ofNa+/K+ 
homeostasis is th~ largest drain of metabolic energy in the brain (A strop, 1982), 
stabilizing the tendency for membrane leakage of these ions will help to conserve 
ATP. Once synaptic transmission becomes depressed(--- 30- 60 seconds after 
initiation of ischemia), 50 % of the remaining energy consumption is used to 
maintel;in Na+/K+ homeostasis (Whittam, 1962). Under hypothermic conditions, 
decreased utilization of A TP stores during the ischemic period should lead to an 
increase in the duration of ischemia that a cell can endure without injury. During 
anoxic/aglycemic conditions in vitro, hypothermia (30 - 31 °C) either prevents the 
occurrence of negative DC shifts (resembling spreading depression), or delays 
the time to the onset of these negative shifts (Hiramatsu et al., 1993; Taylor and 
Weber, 1993). This is believed to be due to decreased utilization of ATP during 
ischemia at hypothermic conditions. Under normothermic conditions, the 
appearance of negative DC shifts has been linked to irreversible neuronal injury 
(Somjen et al., 1990; Rossmann, 1994). In addition, if less ATP is used during 
ischemia then the accumulation of lactic acid will also be decreased, which could 
be protective by minimizing the ischemia-induced reduction in pH. 
Another pathological change induced by ischemia, which is associated 
with irreversible injury, is prolonged inhibition of protein synthesis. Five minutes 
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of forebrain ischemia in the gerbil, at normothermia, will permanently suppress 
protein synthesis in vulnerable brain regions most notably the CAl sector 
(Nowak et al., 1985; Nakagomi et al., 1993). In the rat 4VO model, 30 minutes of 
ischemia will also result in permanent suppression of protein synthesis if brain 
temperature is maintained at normothermic levels. However, decreasing the 
intraischemic brain temperature to 30 oc promotes recovery of protein synthesis 
in the CAl region within 2 hours (Widmann et al., 1993). Thus, intraischemic 
hypothermia does not prevent the initial suppression of protein synthesis that is 
seen throughout the forebrain, but it results in an accelerated recovery. 
Hypothermia has also been found to decrease transmitter release, with or 
without ischemia (Mitani and Kataoka, 1991; Hiramatsu et al., 1993). During 
ischemia, the extracellular accumulation of glutamate is thought to be primarily 
from non-vesicular release (Ikeda et al., 1989; Lohner and Lipton, 1990; 
Szatkowski et al., 1990; Zini et al., 1993). This Ca2+-independent release of 
glutamate appears to be temperature sensitive, i.e., decreased temperature leads 
to decreased release of transmitter (Mitani and Kataoka, 1991 ). If glutamate does 
play a role in the subsequent cell death, then at least part of the protective action 
of hypothermia is attributable to a reduction in glutamate levels during ischemia. 
In addition, if there is less transmitter released during ischemia, then this will 
reduce the energy expenditure necessary during the postischemic period to 
restore homeostasis, thereby helping to better couple metabolic demand to blood 
flow. 
Many of the same mechanisms outlined for intraischemic hypothermia 
could contribute to the protection offered by hypothermia postischemically. The 
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protective effect of even mild, postischemic hypothermia (a decrease of only 1 - 2 
°C) is somewhat surprising. However, very small decreases in temperature, for 
example 1 °C, can decrease metabolic rate by 10 %(Gordon et al., 1984). 
Following reperfusion, blood flow is briefly increased above normal levels, 
followed by hypoperfusion about 10 minutes postischemia (Schmidt-Kastner and 
Freund, 1991 ). Since the level of blood flow during this period of hypoperfusion 
is normally inadequate to meet metabolic demand, postischemic hypothermia 
could help to couple the metabolic rate to the blood flow level by reducing 
metabolic demand. 
A recent hypothesis to explain the death of CAl neurons after ischemia 
has suggested that synaptic activation of CAl cells during the postischemic 
period is the critical factor underlying cell death. For example, Crain et al. (1988) 
and Hsu and Buzsaki (1993) proposed that the early death of the hilar and CA3 
interneurons (during the trrst 24 hours postischemia) increases excitatory 
transmission through the hippocampus and is responsible for the death of the 
CAl neurons that becomes evident~ 72 hours postischemia. Hypothermia 
following ischemia would reduce the excitatory drive on CAl cells and could 
account for the observed protection. Although an appealing hypothesis, some 
pharmacological treatments that rescue hilar intemeurons do not protect CA 1 
. 
pyramidal cells (Honey et al., 1995). 
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6.4 Glutamate Excitotoxicity: Involvement of the AJ\tlPA Receptor? 
.The present experiments using the AMP A receptor antagonist, NBQX, 
have not yielded evidence favouring the glutamate excitotoxicity hypothesis . 
Previous pharmacological studies involving NBQX have been confounded by 
hypothermia, as were the original studies with the non-competitive NMDA 
receptor antagonist, MK-801. The subtlety of the hypothermia induced by 
NBQX may explain why it was missed with only one sampling of rectal 
temperature (Sheardown et al., 1990). The inability ofNBQX to protect CAl 
neurons when br~in temperature is regulated suggests that activation of the 
AMP A receptor does not serve a critical role in ischemic cell death. However, 
the duration of any treatment is an important factor with respect to neuronal 
protection. Most pharmacological studies investigating ischemia employ a 
single dose of a drug. If neuroprotection is not obtained the drug is usually not 
pursued further. However, in order to protect neurons from ischemic damage, 
drug studies may need to be approached in the same way as recent experiments 
using postischemic hypothermia. Colbourne and Corbett (1994a) have shown a 
striking improvement in efficacy by increasing the duration of postischemic 
hypothermia from 12 hours to 24 hours. NBQX induces a prolonged period of 
hypothermia, but this temperature effect might be due to a non-specific effect of 
the drug, such as kidney toxicity (Xue et al., 1994). The half-life ofNBQX (30 
mg/kg, intravenous bolus) in the mouse is 4 hours (Dalgaard et al., 1994). In 
ischemia studies the higher dose and different route of administration ofNBQX 
(90 mg/kg, i.p.) may result in a longer duration of action, but if the half-life is only 
a few hours then multiple injections ofNBQX may be needed to maintain an 
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effective level of receptor blockade over -- 24 - 48 hours. While theoretically 
possible, the toxicity of this compound would probably preclude repeated 
dosing. 
In addition to the negative results reported in this thesis with NBQX, 
other problems with the original hypothesis of glutamate-AMP A toxicity have 
arisen. There has been difficulty in replicating the fmdings of Pellegrini-
I 
Giampietro et al. (1992, 1994) who found a decrease in the mRNA for the GluR2 
subunit after ischemia. Thus, there may not be a reduction in the subunit which 
is responsible for the Ca2 + -impermeability property of the AMP A receptor 
(Diemer et al., 1994). Therefore, the hypothesis that postischemic activation of 
the AMP A receptor results in increased calcium entry through the associated ion 
channel may not be valid. This view is consistent with the lack of neuronal 
protection found with NBQX, when hypothermia is prevented. 
6.5 Importance of Functional Assessments 
Assessment of ischemic injury simply by counting neurons in the CAl 
sector ·obviously does not provide the valuable information that can be obtained 
when functional tests are combined with a histological evaluation. In the 
absence of a reliable functional assessment, erroneous conclusions regarding the 
efficacy of a treatment can be easily made. For example, by assessing the 
protection afforded by NBQX at 4 days with cell counts as the outcome measure, 
it would have been concluded that NBQX provides virtually complete protection 
of CAl neurons. However, the electrophysiological assessment at 4 days does 
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not support this conclusion and it appears that with increasing survival time 
histological protection is completely lost (Li and Buchan, 1995). In the mid-
1980's cell death in the hippocampus was thought to be complete by,.... 72 hours 
and this led investigators to assess protective treatments histologically following 
survival times of 4 - 7 days. More recent data show that certain treatments can 
postpone the time course of cell death (i.e. Morse and Davis, 1990; Dietrich et al., 
1993; Colbourne and Corbett, 1994a, 1995; Li and Buchan, 1995), however, from 
the data currently available, we do not know how long the cell death process can 
be extended. Colbourne and Corbett (1995) used a survival time of6 months to 
assess the protective value of postischemic hypothermia. The protection of CA 1 
neurons declined from,.... 90% at 30 days to,.... 70% at 6 months, however, since 
only two time points were assessed it is not certain whether cell death was still 
continuing at 6 months, or whether the 20 % loss occurred soon after the 30 day 
survival time (perhaps between 1 and 2 months). Since it is unknown at what 
point it is reasonable to conclude permanent neuroprotection has been 
achieved, the addition of functional measures should help when assessing 
potentially protective therapies for ischemic injury. For example, if the animals in 
the above postischemic hypothermia study had been assessed 
electrophysiologically at 6 months and the resulting field potentials were ,.... 70 % 
of normal, then this would represent stronger evidence that the level of 
protection was permanent. If field potentials were less than 70 %, this would 
indicate that a percentage of the CAl cell population was non-functional and 
might be continuing to die. Interestingly, the behavioural measures recorded in 
the open field during the frrst week after ischemia in this study suggest that the 
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protection of postischemic hypothermia is incomplete, even though cell counts 
at this are 90% or greater. This indicates that early functional testing is a better 
predictor of eventual histological outcome than early histological assessment. 
Other similar f"mdings have recently been obtained in our laboratory in 
experiments with ischemic preconditioning (Corbett et al., 1995). Ischemic 
preconditioning is a phenomenon whereby brief durations of ischemia (e.g. 1.5-2 
minutes) that are not lethal to CA 1 cells "protect" against a subsequent ischemic 
episode (e.g. 5 minutes) that would ordinarily destroy 95% of these neurons 
(Kitagawa et al., 1990). In our experiments animals were exposed to two 1.5 
minute periods of ischemia, separated by an interval of 24 hours, followed 3 days 
later by a 5 minute occlusion. Field potentials recorded 4 days postischemia from 
animals who had received ischemic preconditioning were only "' 50 % of normal, 
whereas the CAl cell counts suggested that protection was"' 90% (Corbett et 
al., 1995). Open field activity levels in these preconditioned animals were as high 
as the levels in animals with near total CA 1 destruction. Longer survival times 
assessed with the preconditioning treatment indicate that histological protection 
declines to 70- 80% of control at 10 days and--- 50% of control at 30 days 
(Crooks and Corbett, manuscript in preparation). As shown with NBQX, the 
ischemic preconditioning data also demonstrates a dissociation between indices 
of functional and · histological protection. 
The functional approach developed to evaluate potentially beneficial 
treatments in global ischemia could be improved by the addition of other 
behavioural tests and electrophysiological indices. However, if this approach is 
to be routinely used to assess a pharmacological treatment it is necessary to 
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keep the assessment measures simple, otherwise it becomes impractical for 
pharmacological studies where multiple groups of animals are required. While 
other types of behavioural tests (e.g. maze tests) have been used to evaluate 
animals following ischemia, none have been found to have the sensitivity ofthe 
open field test. In addition, many of these tests are either too labour intensive 
(e.g. T-maze and Morris milk maze) or do not distinguish between sham-operated 
and ischemic animals. However, additional electrophysiological tests, such as 
long-term potentiation (L TP), may prove useful. L TP is a long-lasting change in 
I 
synaptic strength induced by a brief period of high frequency activation, that 
was originally described by Bliss and Lemo (1973). It is widely believed that LTP 
is a good neurobiological model for identifying molecular processes involved in 
long-term memory formation. L TP has been assessed in hippocampal slices 
taken from animals that were made ischemic in vivo (Hori and Carpenter, 1994), 
animals with chronic low blood flow (Sekhon et al., 1994), and animals subjected 
to traumatic brain· injury (Miyazaki et al., 1992). In all cases, the histological 
appearance of CAl and nearby neurons was unchanged from controls, whereas 
there was a significant reduction in the success of L TP induction. Thus, 
measuring the capacity of CA 1 cells to express and maintain L TP could be used 
as a sensitive functional marker of CAl neuronal integrity. In the early stages of 
cell death, synaptic currents may be normal but neuronal functions such as 
intracellular signaling may be abnormal. 
The functional measures described in this thesis were designed to gauge 
hippocampal functioning after global ischemia. However, a similar approach 
could also be used in models of focal ischemia. Most focal models involve 
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occlusion of the middle cerebral artery which leads to cortical and varying 
degree~ of striatal damage in the hemisphere ipsilateral to the occlusion. 
Typically, functional deficits, such as circling and contralateral paralysis or 
weakness are seen in these focal models. 
A sensitive test for cortical damage is the measurement of forepaw 
dexterity, and the "staircase test" has been designed for this purpose in rodents 
(Montoya et al., 1991). This staircase test has recently been used in our 
laboratory to assess neuroprotection in a focal ischemia model (Peeling, Auer, 
Buchan, Saunders, Corbett and Palmer, manuscript in preparation) and appears to 
be more sensitive than routinely used histological endpoints, which measure 
infarct volumes. As in global ischemia, electrophysiological measures could be 
incorporated into focal studies by examining responses from cortical slices taken 
from the hen1isphere affected by the occlusion. Regions that are infarcted would 
not be useful but cortical slices from regions bordering the infarct, the "ischemic 
penumbra", could be utilized to determine the size of the field potentials. In order 
to carry out a histological evaluation, in the same animals, slices could be 
immersion fixed after recording. Functional assessment is potentially more useful 
in focal ischemia models than it has been for global ischemia models. In global 
ischemia, the detection and quantification of CA 1 neuronal loss is relatively 
simple due to the laminar organization of the hippocampus. However, the degree 
of injury in most focal studies is based solely upon calculating infarct volume 
with image analysis techniques. While the infarcted region (which appears 
unstained) is easily determined, quantification of partial neuronal loss in cell rich 
regions surrounding the ischemic core (i.e. the penumbra) is problematic. In 
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addition, surviving neurons, like those in global ischemia, may be viable, but 
functionally abnormal. Thus, functional outcome measures should be included 
in focal ischemia studies as well. 
Any treatment which is being considered for clinical trials should not 
proceed until it has been demonstrated that it provides functional protection as 
well as histological protection comparable to what was demonstrated in the 
present experiments with intraischemic hypothermia. In addition, such 
treatments must also yield protection with survival times of at least several 
months, to reduce the likelihood that cell death is only being delayed. Without 
these minimal criteria being met, it is likely that laboratory derived therapies will 
fail when assessed clinically. This could lead to the conclusion that animal 
models are not relevant to human stroke. Instead, the discrepancies in 
neuroprotection may be due entirely to the use of inadequate assessment 
measures during preclinical (i.e. animal models) testing. Recognition of the 
importance of functional assessment and the demonstration of permanent versus 
transitory neuroprotection should allow basic science research to provide a truly 
effective therapy for acute stroke. 
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